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“Where an activity raises threats of harm to the environment or human health, 
precautionary measures should be taken even if some cause-and-effect relationships 
are not fully established scientifically.”
Wingspread Statement on the 
Precautionary Principle. 
Wingspread Consensus Conference, 
Wingspread Conference Center, Racine, 
Wisconsin. 
January 23-25, 1998.
Abstract
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder 
and, although the pathogenesis of ASD is yet to be established, contemporary 
research indicates that an environmental trigger may play a critical role. One 
proposed environmental trigger that has been the subject of considerable interest and 
controversy is that of mercury (Hg). The mounting evidence that Hg is associated 
with ASD is compelling, but not definitive. It was the intention of this thesis to 
explore the potential relationship between Hg and ASD via an interdisciplinary 
approach. Five published papers are presented in this thesis:
Paper 1a is a critical opinion piece (Chapter 2; Shandley & Austin, 2010). The 
premise of the paper is that progressive biomedical research on autism has been slow 
to emerge, possibly due in part to the investigative approach of Leo Kanner and Hans 
Asperger, and the influential role of their personal backgrounds and clinical training 
in psychoanalysis. Paper 1b appears as a chapter in a book (Chapter 2; Shandley & 
Austin, 2011). The chapter is aimed at postgraduate psychology students, 
encouraging them to become informed users of the Diagnostic and Statistical Manual 
(DSM) by critically examining the information and criteria for ASD. This chapter 
extends upon the arguments of paper 1a, with a greater emphasis on the appearance 
of ASD in the DSM, its revision over subsequent editions, and some of the 
associated controversies.
Paper 2 reports on the first empirical study presented in this thesis (Chapter 4;
Austin & Shandley, 2008). The study analysed the urinary porphyrin profiles of a 
sample of Australian children diagnosed with ASD. The mean urinary porphyrin 
levels from this study were compared against the mean levels reported by Nataf et al. 
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(2006) and Geier and Geier (2007) for their ASD and control groups. In addition, the 
porphyrin levels from all studies were compared to an external control group of 
typically developing children (Minder & Schneider-Yin, 1996). The purpose of the 
study was to establish whether the porphyrin profiles of a sample of Australian 
children exhibit a pattern indicative of Hg damage. This was a critical first study as 
no previously published studies had investigated Hg damage among a sample of 
Australian children diagnosed with ASD by using porphyrin profiles (or by any other 
means). The hypothesis that the porphyrin levels of the Australian ASD group would 
be elevated in comparison to the other three control groups was supported. Although 
there were limitations to this study, the results indicated that a larger, controlled 
urinary porphyrin study was warranted. 
Paper 3 reports on the second empirical study presented in this thesis (Chapter 
5; Shandley, Austin & Bhowmik, 2014). This study was designed to address the 
limitations of the first porphyrin study (small sample size, lack of appropriate control 
group) and extend upon previous porphyrin studies by determining whether, (1) 
group membership, and (2) ASD severity could be predicted using porphyrin 
profiles. Porphyrin levels were compared across three groups of children: (a) 
children diagnosed with ASD, (b) siblings of children diagnosed with ASD (internal 
sibling control), and (c) children with no known blood relative diagnosed with an 
ASD (external control). The study failed to find a difference between urinary 
porphyrins across the three groups. Furthermore, neither group membership, nor 
ASD severity could be predicted based upon urinary porphyrins. However, the result 
needs to be considered in light of the potential unreliability of urinary porphyrins as a 
measure of Hg damage for younger cohorts.
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Paper 4 reports on the final empirical study presented in this thesis (Chapter 6; 
Shandley & Austin, 2011). This study took a different approach to examine whether 
an association exists between Hg and ASD. The concept for this study was based on 
a component of the Hg-autism hypothesis which postulates that ASD develops due to 
an interaction between a genetic susceptibility and environmental trigger (Bernard et 
al., 2001). Therefore, this study investigated whether an individual susceptibility to 
Hg is heritable (and therefore genetic). A cohort of people with a known sensitivity 
to Hg (survivors of pink disease) was surveyed to determine the prevalence of ASD 
among their descendants. The ASD prevalence rate was then compared to the 
prevalence rates for a range of clinical conditions (matched by birth year). The 
results of the study found the prevalence of ASD among the grandchildren of pink 
disease survivors to be significantly higher (6-7 fold) than the comparable general 
population ASD prevalence rate. Furthermore, the results indicate that there was not 
an elevated risk for disease generally among the pink disease cohort, but rather a 
specific risk for ASD.
Based upon the studies undertaken in the present thesis it is not possible to 
definitively conclude whether there is an association between Hg and ASD. The 
apparent association between Hg and ASD appears to be considerably more complex 
than proposed and is likely mediated by physiological and/or Hg characteristics. It is 
clear that several challenging, multifactorial studies will be required to understand 
the nature of the association between Hg and ASD, if one indeed exists.
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Chapter 1: Autism Spectrum Disorder
Overview
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder 
with no known cause or cure. It is a devastating, life-long and often debilitating 
condition which manifests in the first few years of life. The most recent US figure 
estimates ASD prevalence to be as high as 1 in 50 among 6-17 year old children 
(Blumberg et al., 2013), with a male to female ratio of 4:1 (Fombonne, 2003). 
Although the symptoms and degree of severity vary widely, ASD is characterised by 
(i) impairments in reciprocal social interactions and verbal and non-verbal 
communication skills, and (ii) stereotyped behaviour, interests and activities
(American Psychiatric Association [APA], 2013). The cost to families and society of 
a child diagnosed with ASD is considerable, regardless of the child’s cognitive 
ability (Jarbrink & Knapp, 2001). The annual cost of ASD cases in Australia has 
been estimated to range from AUD$4.5-$7.2 billion (Synergies Economic 
Consulting, 2007). The lifetime per capita incremental societal cost of an individual 
with ASD is estimated to range from US$3.5-$5 million, of which lost productivity 
and adult care comprise the largest components (Ganz, 2007). For children aged 0-14
years, ASD is the second leading cause of burden of disease/injury for males and 
eighth for females (Begg et al. 2007).
Diagnosis
Diagnostic and Statistical Manual of Mental Disorders
Autism: Eugen Bleuler, a Swiss psychiatrist invented the term autism in 1910-
11 to provide a rich description of schizophrenia (Grinker, 2007). It is in this context 
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that the term autism first appeared in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM) first edition and subsequent second edition in 1952 and 1968 
respectively (APA, 1952, 1968). In contrast to our understanding today of autism as 
a discrete diagnostic entity, the term was used purely as a behavioural descriptive
under the category of ‘schizophrenia, childhood type.’
In a paper published in 1943 in the now defunct journal Nervous Child, Leo 
Kanner, an Austrian-born, German-educated psychiatrist, published his seminal 
paper ‘Autistic disturbances of affective contact’ in which he describes in great detail 
the behavioural characteristics and ‘peculiarities’ of 11 children and their parents
(Kanner, 1943). It is in this paper that Kanner first introduces a new condition which 
he labelled ‘early infantile autism.’ Although Kanner did not specify diagnostic 
criteria, he did note that “the outstanding, ‘pathognomonic,’ fundamental disorder is 
the children’s inability to relate themselves in the ordinary way to people and 
situations from the beginning of life (p.242, quotation and italics in the original).” 
Some years later, following the release of the first edition of the DSM, Kanner and 
Eisenberg (1956) used Kanner’s narratives to identify six diagnostic features: (a) a 
profound lack of affective contact with other people, (b) an anxiously obsessive 
desire for the preservation of sameness in the child’s routines and environment, (c) a 
fascination for objects, which are handled with skill in fine motor movements, (d) 
mutism or a kind of language that does not seem intended for inter-personal 
communication, (e) good cognitive potential shown in feats of memory or skills on 
performance tests, and (f) onset from birth or before 30 months. Two diagnostic 
criteria were regarded as essential to a diagnosis of autism: (1) a profound lack of 
affective contact, and (2) elaborate repetitive, ritualistic behaviour. However, autism 
did not appear in the DSM as a clinical condition until the third edition as ‘infantile 
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autism’ within a new class of conditions titled Pervasive Developmental Disorders 
(APA, 1980).
Rutter (1978) was widely attributed for operationalizing Kanner’s narratives 
into the definition of infantile autism published in the DSM-III. This also marked the 
introduction of the ‘triad of impairments’ or ‘triad of autistic behaviours,’ whereby a 
diagnosis of autism was made if a child demonstrated gross deficiencies in (a) social 
interaction and (b) language development (relative to their age), and (c) displayed
bizarre and/or repetitive behaviours (APA, 1980). The DSM-III criteria also 
includes: (d) pervasive lack of responsiveness to others, (e) absences of delusions, 
hallucinations, loosening of associations, and incoherence as in Schizophrenia, and 
(f) onset before 30 months of age.
Substantial revisions were made in the DSM-III-R, with the criteria broadened 
to reflect a developmental orientation and the heterogeneity of autism (APA, 1987). 
The DSM-III-R criteria comprised of 16 items, eight of which must be present, with 
a minimum of two items from social interaction, one from communication and one 
from repertoire of activities and interests required for a diagnosis to be made (see 
Table 1). The age of onset was also increased by 6 months (from 30 to 36 months of 
age). Additionally, the name was changed from early infantile autism to Autistic 
Disorder. The subsequent fourth edition and text revision largely retained the same 
definition (APA, 1994, 2000), although the number of diagnostic criteria was 
reduced in the DSM-IV-TR with a minimum of 6 out of 12 items required to be 
present for a diagnosis to be made (see Table 2).
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Table 1
Diagnostic criteria for Autistic Disorder (DSM-III-R, 1987)
At least eight of the following sixteen items are present, these to include at least two items 
from A, one from B, and one from C.
A. Qualitative impairment in reciprocal social interaction as manifested by the 
following
1. Marked lack of awareness of the existence or feelings of others;
2. No or abnormal seeking of comfort at times of distress;
3. No or impaired imitation;
4. No or abnormal social play; and
5. Gross impairment in ability to make peer friendships.
B. Qualitative impairment in verbal and nonverbal communication and in 
imaginative activity, as manifested by the following:
1. No mode of communication, such as, communicative babbling, facial 
expression, gesture, mime, or spoken language;
2. Markedly abnormal nonverbal communication, as in the use of eye-to-eye 
gaze, facial expression, body posture, or gestures to initiate or modulate 
social interaction;
3. Absence of imaginative activity, such as play-acting of adult roles, fantasy 
character or animals; lack of interest in stories about imaginary events;
4. Marked abnormalities in the production of speech, including volume, pitch, 
stress, rate, rhythm, and intonation;
5. Marked abnormalities in the form or content  of speech, including 
stereotyped and repetitive use of speech; use of "you" when "I" is meant; 
idiosyncratic use of words or phrases; or frequent irrelevant remarks; and
6. Marked impairment in the ability to initiate or sustain a conversation with 
others, despite adequate speech;
C. Markedly restricted repertoire of activities and interests as manifested by the 
following:
1. Stereotyped body movements;
2. Persistent preoccupation with parts of objects or attachment to unusual 
objects;
3. Marked distress over changes in trivial aspects of environment;
4. Unreasonable insistence on following routines in precise detail;
5. Markedly restricted range of interests and a preoccupation with one narrow 
interest
D. Onset during infancy or early childhood
x Specify if childhood onset (after 36 months of age)
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Table 2
Diagnostic criteria for Autistic Disorder (DSM-IV-TR, 2000) 
A. A total of six (or more) items from (1), (2), and (3), with at least two from (1), and one 
each from (2) and (3): 
1. Qualitative impairment in social interaction, as manifested by at least two of the 
following: 
a. Marked impairment in the use of multiple nonverbal behaviors such as eye-
to-eye gaze, facial expression, body postures, and gestures to regulate social 
interaction 
b. Failure to develop peer relationships appropriate to developmental level 
c. A lack of spontaneous seeking to share enjoyment, interests, or 
achievements with other people 
d. Lack of social or emotional reciprocity 
2. Qualitative impairments in communication as manifested by at least one of the 
following: 
a. Delay in, or total lack of, the development of spoken language (not 
accompanied by an attempt to compensate through alternative modes of 
communication such as gesture or mime) 
b. In individuals with adequate speech, marked impairment in the ability to 
initiate or sustain a conversation with others 
c. Stereotyped and repetitive use of language or idiosyncratic language 
d. Lack of varied, spontaneous make-believe play or social imitative play 
appropriate to developmental level 
3. Restricted repetitive and stereotyped patterns of behavior, interests, and 
activities, as manifested by at least one of the following: 
a. Encompassing preoccupation with one or more stereotyped and restricted 
patterns of interest that is abnormal either in intensity or focus 
b. Apparently inflexible adherence to specific, nonfunctional routines or 
rituals 
c. Stereotyped and repetitive motor manners
d. Persistent preoccupation with parts of objects
B. Delays or abnormal functioning in at least one of the following areas, with onset prior 
to age 3 years: (1) social interaction, (2) language as used in social communication, or 
(3) symbolic or imaginative play. 
C. The disturbance is not better accounted for by Rett’s Disorder or Childhood 
Disintegrative Disorder
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Asperger’s Disorder: Hans Asperger, an Austrian-born psychiatrist and 
paediatrician, published the first definition of Asperger’s Disorder in 1944 
(Asperger, 1944). Although Asperger’s paper only described four young boys, he
discerned a pattern of behaviour and abilities that he called ‘autistic 
psychopathology.’ While Asperger identified his self-named disorder around the 
same time that Kanner described autism, it was not included as a discrete clinical 
condition in the DSM until the fourth edition (and continued in the text revision of 
this edition) (APA, 1994, 2000). Asperger’s paper was not translated into English 
until 1981 (Frith, 1991), and it is possible that this delay affected the timing of the 
appearance of Asperger’s Disorder in the DSM. The primary difference between 
Asperger’s Disorder and Autistic Disorder in the DSM-IV and DSM-IV-TR is that 
there is comparatively less disability in Asperger’s. This is reflected in the diagnostic 
requirement in that only two of the ‘triad of autistic impairments’ be present (see 
Table 3).
Autism Spectrum Disorder: In May 2013, ASD was formally established as a 
discrete diagnostic entity in the fifth edition of the DSM, replacing the individual 
diagnostic labels of Autistic Disorder, Asperger’s Disorder, Pervasive 
Developmental Disorder–Not Otherwise Specified (PDD-NOS), and Childhood 
Disintegrative Disorder (APA, 2013). A second major change in the DSM-5 is the 
reduction of three diagnostic domains to two, with social interaction and 
communication collapsed into one domain (see Table 4). Formerly, the diagnostic 
label itself designated the clinical severity, however, the DSM-5 separates severity 
into three levels each for social communication and restricted, repetitive behaviors 
based upon level of support required with level one needing the least support to level 
three needing the most.
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Table 3
Diagnostic criteria for Asperger’s Disorder (DSM-IV-TR, 2000)
A. Qualitative impairment in social interaction, as manifested by at least two of the 
following:
1. Marked impairment in the use of multiple nonverbal behaviors such as eye-to-
eye gaze, facial expression, body postures, and gestures to regulate social 
interaction
2. A lack of spontaneous seeking to share enjoyment, interests, or achievements 
with other people 
3. Failure to develop peer relationships appropriate to developmental level
4. Lack of social or emotional reciprocity
B. Restricted repetitive and stereotyped patterns of behavior, interests, and activities, as 
manifested by at least one of the following:
1. Encompassing preoccupation with one or more stereotyped and restricted 
patterns of interest that is abnormal either in intensity or focus
2. Apparently inflexible adherence to specific, nonfunctional routines or rituals
3. Stereotyped and repetitive motor mannerisms
4. Persistent preoccupation with parts of objects
C. The disturbance causes clinically significant impairment in social, occupational, or
other important areas of functioning. 
D. There is no clinically significant general delay in language.
E. There is no clinically significant delay in cognitive development or in the 
development of age-appropriate self-help skills, adaptive behavior (other than in 
social interaction), and curiosity about the environment in childhood.
F. Criteria are not met for another specific Pervasive Developmental Disorder or 
Schizophrenia
Changes in the DSM-5 have been met with a great deal of apprehension. There 
is concern that the new diagnostic criteria will fail to identify some individuals 
thereby restricting their access to services and sources of funding (Mayes, Black & 
Tierney, 2013). Anger has also been leveled at the decision to remove the label 
Asperger’s Disorder and group it with the more severe condition autism. Arguments 
reflect, in part, a loss of identity and fear of being stereotyped alongside autism
(Giles, 2014).
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The diagnostic process
The diagnosis of ASD typically relies on a behavioural assessment conducted 
by a trained psychologist or psychiatrist. A considerable number of screening and 
diagnostic instruments are available, although the Autism Diagnostic Observation 
Schedule (Lord, Rutter, DiLavore & Risi, 2001) is generally considered the gold 
standard. Of paramount importance to the long-term well-being and development of 
the child is a reliable and timely diagnosis. Logically the earlier an accurate 
diagnosis can be made, the earlier suitable interventions can commence. A report 
prepared by Synergies Economic Consulting (2012) for the Australian Autism Early 
Intervention Outcomes Unit (AEIOU) Foundation provides a comprehensive outline 
of studies demonstrating the beneficial impacts of early intervention strategies in 
relation to education (i.e., improved cognitive functioning [IQ], decreased need of 
special schooling), and improved employment outcomes, independence, and quality 
of life for the affected individual and their families.
A fundamental challenge to the diagnosis of ASD is the reliance on the 
observation of a set of behavioural symptoms. Essentially this means that the 
diagnostic process requires that the child reach an age whereby the behaviours would 
typically be present (at least 2-3 years). Although recent research indicates that signs 
of ASD may be present as young as 12 months of age (Barbaro & Dissanayake, 
2010), questions of reliability arise, especially for children presenting with symptoms 
consistent with the lower end of the spectrum and those with comorbid conditions. 
Emerging research also indicates that ASD may be a biological disorder of brain 
development/function (Voineagu et al., 2011) suggesting the possibility of molecular 
testing, in conjunction with clinical evaluation, as another avenue in the diagnostic 
process. However, at this time, diagnosis remains an inherently subjective process.
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Table 4
Diagnostic criteria for Autism Spectrum Disorder (DSM-5, 2013)
1. Persistent deficits in social communication and social interaction across multiple 
contexts, as manifested by the following, currently or by history:
x Deficits in social-emotional reciprocity, ranging, for example, from abnormal 
social approach and failure of normal back-and-forth conversation; to reduced 
sharing of interest, emotions, or affect; to failure to initiate or respond to social 
interactions
x Deficits in nonverbal communicative behaviors used for social interaction, 
ranging, for example, from poorly integrated verbal and nonverbal 
communication; to abnormalities in eye contact and body language or deficits in 
understanding and use of gestures; to a total lack of facial expression and 
nonverbal communication.
x Deficits in developing, maintaining, and understanding relationships, ranging, for 
example, from difficulties adjusting behavior to suit various social contexts; to 
difficulties in sharing imaginative play or in making friends; to absence of interest 
in peers.
Specify current severity:
x Severity is based on social communication impairments and restricted, 
repetitive patterns of behavior
2. Restricted, repetitive patterns of behavior, interests, or activities, as manifested by at 
least two of the following, currently or by history:
x Stereotyped or repetitive motor movements, use of objects, or speech
x Insistence on sameness, inflexible adherence to routines, or ritualized patterns of 
verbal or nonverbal behavior
x Highly restricted, fixated interests that are abnormal in intensity or focus 
x Hyper- or hypo-reactivity to sensory input or unusual interest in sensory aspects of 
the environment
Specify current severity:
x Severity is based on social communication impairments and restricted, 
repetitive patterns of behavior.
1. Symptoms must be present in the early developmental period (but may not become 
fully manifest until social demands exceed limited capacities, or may be masked by 
learned strategies in later life).
2. Symptoms cause clinically significant impairment in social, occupational, or other 
important areas of current functioning.
3. These disturbances are not better explained by intellectual disability (intellectual 
developmental disorder) or global developmental delay. Intellectual disability and 
autism spectrum disorder frequently co-occur; to make comorbid diagnoses of autism 
spectrum 
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Prevalence
The first epidemiologic study of autism was conducted in 1966 in England
(Wing, 1993). The study applied Kanner’s criteria to a large, population-based 
methodology establishing a prevalence rate of 4-5 cases per 10,000, or approximately 
1 in 2500 children. Other epidemiological studies published prior to 1985 using 
Rutter’s criteria and variations thereof, found prevalence rates ranging from 1.9 to 
6.0 cases per 10,000 children (Centers for Disease Control [CDC], 2001; Yeargin-
Allsopp & Rice, 2004). Prevalence figures from published studies between 1985 and 
1995 indicate that the number of autism cases doubled with the mean prevalence rate 
reaching 11.8 cases per 10,000 children (CDC, 2001). Similarly, Fombonne (2005) 
reported an increase from 4.4 to 12.7 cases per 10,000 children between studies 
published in 1966 to 1991 and 1992 to 2001. ASD prevalence rates reported by the
Autism and Developmental Disabilities Monitoring network show an increase from 
6.7 cases per 1,000 (approximately 1 in 150) in 2000 to 11.3 cases per 1000 
(approximately 1 in 88) in 2008 among 8-year old children (CDC, 2007, 2012). The 
most recent US figure to date estimate ASD prevalence to be as high as 1 in 50 
among 6-17 year old children (Blumberg et al, 2013). In Australia, a national study 
determined that the prevalence rate is 1 in 160 children aged 6-12 years 
(MacDermott, Williams, Ridley, Glasson & Wray, 2008). The data was based on 
ASD cases (autism and Asperger’s) known to Centrelink (an Australian federal 
government social service agency) for 2005. More recent estimates suggest 
Australian ASD prevalence may be as high as 1 in 119 children (Barbaro & 
Dissanayake, 2010). 
It has been argued that the rise in ASD prevalence can be fully accounted for 
by widening diagnostic criteria, greater education and awareness, diagnostic 
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substitution and an increase in service availability (Fombonne, Zakarian, Bennett, 
Meng & McLean-Heywood, 2006). At this point in time, there is no definitive 
research as to whether the rise in ASD prevalence is genuine or simply an artefact of 
the aforementioned factors. Until such a time as a conclusion is reached, it is prudent
to assume that the rise is at least partially based on a genuine increase in cases and,
importantly, that ASD is a major public health issue.
Gender and Age Features
Males are approximately four times more likely to meet the criteria for ASD 
than females (Fombonne, 2003). Although the reason for the higher prevalence of 
ASD among males is yet to be determined (Yeargin-Allsopp & Rice, 2004), there is 
some suggestion that ASD may go unrecognised among females due to the 
manifestation of milder social and communication difficulties (Rivet & Matson, 
2011). Genetic differences have also been hypothesised for the difference in 
diagnosis between males and females (Constantino & Charman, 2012; Sato et al., 
2012) 
ASD typically manifests in early infancy where signs of abnormal development 
are present within the first 24 months of life. ASD may also present in a regressive 
form whereby abnormalities in social interaction, communication and/or play 
behaviour appear abruptly following apparent normal development (Baron-Cohen, 
2002).
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Differential Diagnosis and Comorbidity
Differential diagnosis
To diagnose ASD according to the DSM-5 diagnostic criteria, the assessor 
must first eliminate a number of other conditions, specifically, Rett syndrome;
selective mutism; language disorders and social (pragmatic) communication 
disorder; intellectual disability (ID) without ASD; stereotypic movement disorder;
attention-deficit/hyperactivity disorder (ADHD); and schizophrenia.
Comorbidity
ASD is commonly associated with a wide range of intellectual/developmental, 
psychiatric, medical and genetic disorders. Approximately 70% of individuals with 
ASD also meet the diagnostic criteria for ID (LaMalfa, Lassi, Bertelli, Salvini & 
Placidi, 2004). Learning difficulties and developmental coordination disorder are 
also reportedly common (Baird, Douglas & Murphy, 2011). A meta-analysis of 23 
studies conducted by Amiet et al. (2008) showed that the pooled prevalence rates of 
epilepsy ranged from 8% (for those without comorbid ID) to 21.4% (for those with 
comorbid ID). ASD has been associated with increased risks of autoimmune disease, 
specifically, asthma, allergic rhinitis, atopic dermatitis, urticarial, and type 1 diabetes 
(Chen et al., 2013), in addition to sleep problems (Hoffman, Sweeney, Gilliam & 
Lopez-Wagner, 2006), gastrointestinal symptoms (Molloy & Manning-Courtney,
2003), sensory sensitivities (Ben-Sasson et al., 2009; Bogdashina, 2003) and low
muscle tone (De Jong, Punt, De Groot, Minderaa & Hadders-Algra, 2011).
Approximately 70% of individuals with ASD have at least one comorbid mental 
disorder (Simonoff et al., 2008), such as, specific phobia, obsessive-compulsive 
disorder, or ADHD (Leyfer et al., 2006). Genetic disorders including Fragile X, 
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tuberous sclerosis, and Down syndrome have also been associated more commonly 
with ASD than in the general population (Fombonne, 1999).
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Chapter 2: Reconceptualising autism
Autism was originally conceptualised as a psychogenic condition, with the 
implication being that the parents (particularly the mother) was the cause of the 
child’s behaviour. Known as the refrigerator mother theory of autism, it was 
presumed that autism was caused by emotionally cold and distant (‘frigid’) mothers. 
While this theory is attributed to child psychologist Bruno Bettelheim, it is apparent 
that he was at least partially influenced by Kanner’s observations of the parents of 
the afflicted children, stating that they were obsessive, cold-hearted and had limited 
interest in people (Bettelheim, 1967; Kanner, 1943). Rimland’s book ‘Infantile 
autism: the syndrome and its implications for a neural theory of behavior,’ published 
in 1964, was the catalyst in shifting popular opinion away from Bettelheim’s theory. 
The refrigerator mother theory of autism is now largely discredited, but it remains 
influential in some parts of the world, most notably in France, due to the ongoing and 
powerful influence of psychoanalytic theory (Yudell, 2012).
Contemporary research has found ASD to have a strong genetic component 
(Freitag, 2007), and substantial research over the past 2 decades has aimed to find a
gene (or genes) consistent among children with an ASD diagnosis (e.g., Ozonoff et 
al., 2011; Folstein & Rosen-Sheidley, 2001; Rosenberg et al., 2009; Veenstra-
Vander, Weele & Cook Jr, 2004). Nevertheless, studies seeking a single-gene cause 
have been largely inconclusive. A more promising approach to understanding the 
genetic factors involved in ASD is that of epigenetics. Epigenetics refers to non-
permanent heritable changes in organisms caused by the modification of gene 
expression without altering the DNA sequence. Essentially, each cell turns on 
(expresses) only a proportion of genes, while the rest of the genes are turned off 
(repressed). Genes can be turned on or off through a process known as gene 
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regulation. Although the underlying mechanisms are not yet fully understood, the 
environment is considered to have a critical role in epigenetic regulation (Feil & 
Fraga, 2012). A recent review by Hall and Kelley (2014) explored the key findings 
relating to epigenetics in ASD, concluding that “possible epigenetic processes related 
to autism present a new and promising way to investigate the genetic nature of 
autism” (p.878).
Altered glutathione metabolism has also been identified as a potential precursor 
to the development of ASD. Glutathione (L-g-glutamyl-L-cysteinyl-glycine) is an 
intracellular peptide which plays a central role in cell biology and is critical in 
protecting organisms against toxicity and disease (Pastore, Federici, Bertini &
Piemonte, 2003). The glutathione redox ratio, a ratio of glutathione to glutathione 
disulphide (oxidized glutathione), is commonly used as a measure of oxidative stress.
Neurological development may be affected in the early stages of life due to an 
imbalance in the glutathione redox ratio through a decrease in the proliferation of 
cells, DNA damage, and an increase in apoptosis (Main, Angley, O’Doherty, 
Thomas & Fenech, 2012). Furthermore, elevated oxidative stress and decreased 
glutathione has been identified as a possible mechanism by which Hg may induce 
ASD (James et al. 2004; Geier & Geier, 2006a; Youn, in, Kim & Lim, 2010). Thus, 
an individual low in glutathione would have both a diminished capacity to minimise 
oxidative damage produced by Hg and the ability to excrete the toxicant.
Although the aetiology of autism remains elusive, our understanding of the 
disorder has come far since the infamous days of the refrigerator mother theory. 
Advances in understanding have been particularly evident over the last two decades. 
ASD is now largely considered a whole-body condition with 
psychological/psychiatric, biological and medical characteristics, rather than as a 
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pure psychiatric manifestation (Herbert, 2010). While this emergence in 
understanding is obviously important, it was perhaps surprisingly slow. Arguably, 
the cause of this, at least in part, is due to the original writings on autism and 
Asperger’s Disorder by Kanner and Asperger respectively.
Kanner’s seminal paper (1943) provides a detailed observational description, in 
narrative form, of child and parental behavioural characteristics, but makes little
reference to medical or physiological examinations or evaluations. Indeed, it would 
appear that he did not order any such examinations to be performed, only referencing 
those undertaken prior to the commencement of his sessions with each family. 
Asperger’s paper, published in 1944, is remarkably similar in its lack of reference to 
biological or medical testing. Both Kanner and Asperger independently appear to 
have neglected to consider (or were too ready to discount) a medical/biological basis
to the behaviour they were observing, and instead chose to declare a new psychiatric 
condition. In the context of both authors’ psychoanalytic training and practice, this is 
perhaps unsurprising. In the two original papers that follow, the potential 
implications that Kanner and Asperger’s respective personal and professional 
background has had on ASD research and practice is discussed, and how this has 
perhaps led to an over-emphasis on the behavioural aspects of the condition, with a 
subsequent under-emphasis on the biological.
The first of the papers (Shandley & Austin, 2010) is a critical opinion piece. 
The basic premise of the paper is that progressive biomedical research on autism has 
been slow to emerge, possibly due in part to the investigative approach employed by
Kanner and Asperger, and the influence of their personal backgrounds and clinical 
training in psychoanalysis. The second paper (Shandley & Austin, 2011) appears as a 
chapter within the book ‘A critical introduction to DSM.’ The book is aimed at 
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postgraduate psychology students and encourages them to become informed users of 
the DSM, critically examining the contents as opposed to accepting the information
at face value. As such, this chapter extends upon the arguments of the first paper in 
the present thesis, with a greater emphasis placed on the appearance of ASD in the 
DSM and some of the associated controversies.
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Paper 1a
Shandley, K. & Austin, D.W. (2010). Reconceptualizing autism: Moving beyond the 
behavioral to address cause, cure and prevention. Autism Insights, 2:25-30.
Reprint of the original open access paper
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Paper 1b
Shandley, K. & Austin, D. (2011). Autism Spectrum Disorders (Chapter 7). In G 
Murray, A Critical Introduction to DSM. New York: Nova Publishers.
Reprinted by permission of the publisher Nova Science Publishers
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Chapter 3: Mercury and Autism Spectrum Disorder
Overview
ASD has a strong genetic component with heritability estimated to be as high 
as 90% (Freitag, 2007). Concordance rates of 60-91% have been demonstrated in 
monozygotic twins in contrast to dizygotic twins where concordance rates are
considerably lower at 0-10% (Folstein & Rosen-Sheidley, 2001; Rosenberg et al., 
2009; Veenstra-Vander, Weele & Cook Jr, 2004). In addition, sibling recurrence risk 
has been estimated to range from 2% to 19% (Ozonoff et al., 2011). Nevertheless, 
heritability alone cannot account for the escalation in ASD prevalence over recent 
decades; the human genome simply cannot evolve that quickly. 
While it has been argued that the rise in prevalence is due to the broadening of 
diagnostic criteria, increased awareness, diagnostic substitution and increased service 
availability (Fombonne et al., 2006), contemporary research suggests that an 
environment trigger, perhaps in conjunction with genetics, is likely to play a role in 
the development of ASD (Herbert, 2010; Hallmayer et al., 2011). In this context, 
environmental triggers encompass many possibilities including pesticides, pollution, 
chemicals, parental age, and maternal or neonatal infection. It is beyond the scope 
and capacity of this thesis to effectively investigate all possible environmental 
factors, however, there is one factor that has been the subject of great controversy 
and debate in recent times, that of the heavy metal mercury (Hg) (Bernard, Enayati, 
Redwood, Roger & Binstock, 2001; Mutter, Naumann, Schneider, Walach & Hayley,
2005). As yet, no definitive science has established whether Hg plays a role in the 
development of ASD, however, a recent review of the area indicated the existence of 
a link of some sort (DeSoto & Hitlan, 2010). 
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Mercury is a naturally occurring element that is ubiquitous in the environment 
(Goldman & Shannon, 2001). It is released into the environment through both natural 
(e.g., volcanoes erupting, soil decomposing) and anthropogenic (e.g., mining, coal-
fired power plant emissions) means. Once released into the environment, Hg 
continuously cycles between the atmosphere, ocean and soil; it does not breakdown 
and cannot be degraded into a harmless substance. Mercury is a known neurotoxin 
and is especially dangerous to the foetal and infant brain and central nervous system
(CNS) (Geidd, 2004; Lebel, Walker, Leemans, Phillips & Beaulieu, 2008; Rodier, 
1995; Thompson et al., 2000). Humans are exposed to Hg through a number of 
sources, primarily, seafood, dental amalgam, and vaccines. The following chapter 
will discuss Hg in further detail and its impact on human health, particularly that of 
neonates and infants, and the association between Hg and ASD. 
Chemistry
Mercury is identified by three main species: elemental, inorganic, and organic 
forms (Franzblau, 1994). Elemental Hg, also known as metallic or liquid Hg, forms a 
shiny, silver-white liquid at room temperature. It is created by smelting cinnabar ore 
and is highly volatile, expanding and contracting at a constant rate as the temperature 
rises and falls. Uncontained in the environment, elemental Hg will evaporate into a 
colourless and odourless vapour that can be both inhaled and absorbed through the 
skin. It is most commonly released into the atmosphere through anthropogenic means 
such as the combustion of fossil fuels. Today, it is most commonly used in dental 
amalgam (silver fillings), thermometers, fluorescent light bulbs, mining, some 
electrical switches (in the workplace, home and car), and the glass-blowing industry.
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Inorganic Hg compounds are formed from the univalent and bivalent cations of 
Hg which include mercurous chloride, mercuric chloride, mercuric acetate and 
mercuric sulphide. Compounds typically appear as white powders or crystals, with 
the exception of mercuric sulphide which is red in its natural state and turns black 
following exposure to light. Inorganic Hg is used in batteries, disinfectants, and skin 
bleaching creams, and is still used today in cultural, ceremonial and religious 
practices as it has been throughout history (Wendroff, 1997; Zayas & Ozuah, 1996).
Organic Hg forms when carbon combines with Hg. Organic Hg compounds 
include dimethylmercury, phenylmercury, and ethylmercury, although the 
predominant and most toxic compound in the environment is methylmercury
(MeHg). Humans are primarily exposed to MeHg through the consumption of fish 
and shellfish. Both elemental and inorganic Hg can be transformed into MeHg via 
bacteria that live in sedimentary layers of lakes and other bodies of water which is 
then bioaccumulated and biomagnified upwards through the aquatic food-chain. That 
is, bottom-dwelling fish feed upon contaminated plant life which are in turn eaten by 
larger fish and so on, concentrating up the food-chain in large predatory fish (e.g., 
king mackerel, shark, swordfish, tuna), freshwater fish (e.g., bass, eels, perch) and 
mammals (e.g., seals, whales) (Dietz et al. 2000; Gilmour & Riedel, 2000; Neumann 
& Ward 1999). Additionally, MeHg contained in landfills and sewerage treatment 
plants can be released directly into sources of water (Lindberg et al. 2001; Sommar,
Feng & Lindqvist, 1999).
Toxicology
All forms of Hg are hazardous to human health, especially to the developing 
brain and CNS as it can cross the placental and blood-brain barrier (Campbell et al. 
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1992; Clarkson, Vyas & Ballatori, 2007; Rodier, 1995). Both the blood-brain barrier 
and CNS continue to develop beyond birth and as such, remain vulnerable to 
environmental insult both in utero and during infancy. Indeed, some regions of the 
brain continue to develop and mature until early adulthood (Geidd, 2004; Lebel et 
al., 2008; Rodier, 1995; Thompson et al., 2000). The toxicology of Hg is complex 
and dependent on a number of factors including form, source, route and duration of 
exposure, and genetic susceptibility to Hg. These factors as they relate to humans,
and more importantly neonatal and infant health are discussed below.
Elemental Hg
Elemental Hg is highly lipophilic in nature, meaning that it can readily enter 
the bloodstream, allowing it to be distributed throughout the body and cross the 
placental and blood-brain barriers (Magos, 1967; Clarkson & Magos, 2006). 
Elemental Hg primarily enters the body via inhalation, with the vapour preferentially 
depositing in the kidneys and brain (Barregård, Sällsten & Conradi, 1999; Berlin, 
Jerksell & von Ubisch, 1966; Cherian & Clarkson, 1976; Florentine & Sanfilippo,
1991). Acute exposure most commonly leads to respiratory distress, including 
pneumonia, bronchiolitis, and oedema (Clarkson & Magos, 2006). The Minimal Risk 
Level for chronic Hg inhalation set by the Agency for Toxic Substances and Disease 
Registry (ATSDR) is 0.2μg/m3 (ATSDR, 1999). Chronic exposure exceeding 
10μg/m3 can affect the CNS resulting in neurological disturbances, tremors, and 
memory loss (Clarkson & Magos, 2006). Additionally, low concentrations of vapour 
may cause skin rashes and kidney abnormalities, while high concentrations have 
resulted in death. Typically, the toxic effects of elemental Hg gradually disappear 
once the individual is removed from the source of exposure. Although, once in the 
brain, elemental Hg vapour can remain at high residual levels for an extensive length 
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of time (Takahata, Hayashi, Watanabe & Anso, 1970). Furthermore, in some cases, 
symptoms have persisted for as long as 30 years following removal from 
occupational sources where exposure to Hg was chronic (Albers et al., 1988). Indoor 
areas contaminated by accidental Hg spills can be extremely difficult to address, 
exposing occupants for months if not years, and in some cases, results in buildings
being necessarily demolished (Carpi & Chen, 2001; Orloff et al., 1997).
Mercury poisoning is especially problematic among school populations in 
countries such as Turkey. For example, Carman et al. (2013) examined the effects of 
elemental Hg poisoning among 179 school children in the Turkish provinces of Kilis 
and Kahramanmaras. The children were exposed to Hg via broken jars containing Hg 
in their school chemistry laboratories. The majority of children were reported to have 
touched or played with Hg in addition to inhaling its vapours. In some cases, children 
took Hg home where the entire family was subsequently poisoned due to Hg being 
boiled, heated and tasted. The most common complaints reported upon admission to 
hospital were headache, visual problems, rashes on the trunk and extremities, nausea,
abdominal pain and peripheral neuropathy. Akyildiz, Kondolot, Kurtoglu and 
Konuskan (2012) likewise reported headache as the most common symptom among 
26 paediatric cases of Hg poisoning exposed through inhalation or dermal absorption 
resulting from a broken thermometer at school.
Inorganic Hg
Inorganic Hg preferentially deposits in the kidneys, followed by the liver. 
Unlike elementary Hg, inorganic Hg has poor lipid solubility, decreasing its ability to 
cross the blood-brain and placental barriers and subsequently enter the brain 
(Kuhnert, Kuhnert & Erhard, 1981). However, maternal levels of inorganic Hg can 
be damaging to the foetus. For example, Brender et al. (2006) found mothers of 
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children with a neural tube defect in comparison to controls were nine times more 
likely to have inorganic urinary Hg levels that exceeded >5.61μg/L. Inorganic 
poisoning occurs primarily through ingestion; however, animal and human case 
studies have shown that both mercurous and mercuric salts can also be absorbed by 
the skin (Barr, Woodger & Rees, 1973; Bourgeois et al., 1986; De Bont, Lauwerys, 
Govaerts & Moulin, 1986).
Famously, Lewis Carroll’s character, the Mad Hatter, is linked to the toxic 
effects of inorganic Hg. In the 17th and 18th century, mercuric nitrate was used to 
treat animal fur in the felting process to make top hats. The ‘eccentric behaviour’ of 
the hatters, due to the chronic inhalation of Hg vapour, led to the expressions 
‘hatter’s shakes’ and ‘mad as a hatter’ and resulted in behaviours that included 
irritability, anxiety, shyness, moodiness, and unpredictability, ataxia, and memory 
loss, in addition to other problems such as the loosening of teeth (Lishman, 1987). 
Mercurous chloride, also known as calomel (sweet Hg), has a long history of 
use in medicinal products for both children and adults. Although calomel was
considered non-hazardous, ingested over an extended period of time it can affect the 
kidneys, gastrointestinal tract and CNS (Wands, Weiss, Yardley & Maddrey, 1974). 
Calomel was once the treatment of choice for syphilis, typhus and yellow fever 
(Ozuah, 2000). For syphilis, calomel was administered via a range of common routes 
(oral, dermal, injection) and more extreme and unusual methods such as fumigation. 
This involved placing the afflicted individual into a box containing Hg and only a 
small hole for the individual to put their head through. A fire was lit underneath the 
box causing Hg to vaporise and slowly be absorbed by the skin over a period of 
hours. Death was not an uncommon result of treatment, while others suffered 
neurological damage, severe teeth loss and ulcerations. Hg remained the primary 
An investigation of the potential association between mercury and ASD        49
treatment for conditions like syphilis from the 17th century until the discovery of 
penicillin (Parascandola, 2009). Indeed, the saying ‘a night with Venus, a lifetime 
with mercury’ originated from the connection between syphilis and Hg as a 
treatment.
Calomel was extensively used in children’s teething powders during the 19th
and 20th century resulting in a condition that became widely known as pink disease 
or acrodynia. Approximately 1 in 500 exposed children experienced some degree of 
Hg poisoning with death resulting in 10-33% of cases (Rocaz, 1933). Although now 
rare, pink disease is still diagnosed on occasion, such as the cases of two brothers
who played with a broken sphygmomanometer (Horowitz, Greenberg, Ling & 
Lifshitz, 2002) and twin girls who were diagnosed after their parents used a teething 
powder they purchased online that still contained Hg (Weinstein & Berstein, 2003). 
Pink disease is characterised by a wide range of symptoms including, irritability, 
neurosis, photophobia, hyperhidrosis, hypotonia, ataxia, digestive problems, 
excessive salivation, respiratory problems, lethargy, slurring/loss of speech, 
loosening/loss of teeth, and a marked reddening of the extremities usually 
accompanied by swelling and peeling of the skin (Rocaz 1933; Wood & Wood 1935; 
Leys 1950). Warkany and Hubbard (1953) reported similar effects (i.e., irritability, 
fretfulness and sleeplessness) on children exposed to calomel through a diaper rinse 
solution as it did to those exposed via teething powders. Research has revealed that 
medical issues are common among adult survivors of pink disease, including 
Young’s syndrome and bronchiectasis (Hendry, A’Hern & Cole, 1993; Williams & 
O’Reilly, 1959). 
Two similar case reports identified neurological side-effects from the use of 
Chinese herbal medicines containing mercurous chloride. A 4-year-old boy given a 
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3-month course of Chinese medicine developed drooling, dysphagia, irregular arm 
movements, and impaired gait (Kang-Yum & Oransky, 1992). In the second case 
report, a 5-year-old boy presenting with mouth ulcers was administered a Chinese 
herbal spray containing 98% inorganic Hg up to 20 times a day over a period of 4-
weeks. The child subsequently become irritable and developed motor and vocal tics 
and rashes on the trunk of his body (Li et al., 2000).
Mercuric chloride, considered more toxic than mercurous chloride, primarily 
affects the kidneys and gastrointestinal tract (Piotrowski, Trojanowska, :LĞQLHZVND-
Knypl & Bolanowska, 1974). Exposure to mercuric chloride (approximately 1 to 4 
grams) has led to death which was attributed to renal failure, cardiovascular collapse, 
and severe gastrointestinal damage (Beasley, Schep, Slaughter, Temple & Michel, 
2014). Acute renal failure in addition to vomiting, blisters and ulcers on the lips and 
tongue has been reported in the case of a 19-month old boy who accidentally 
ingested an unknown amount of mercuric chloride powder (Samuels et al., 1982). 
Organic Hg
In Iraq, two incidents of ethylmercury poisoning occurred in 1956 and 
1959/60. Both outbreaks were traced to the consumption of wheat which had been 
dressed with the mercurial compound Granosan M (ethylmercury-p-
toluenesulfonanilide). Although the wheat came with the warning that it was not to 
be consumed, many families chose to ground it into flour to make bread after first 
testing it on fowls. A latent period ranging from days to weeks was observed before 
either fowl or human began showing any ill effects of Hg poisoning, giving the false 
impression that the wheat was safe to consume. By the time symptoms appeared 
among the first families that had commenced consuming the wheat, it was too late 
for many other families to avoid the same fate. In excess of 100 people were 
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hospitalised and a dozen fatalities recorded following the 1956 incident (Jalili & 
Abbasi, 1961). At least 1000 patients were reported to have been affected by the later 
incident in 1959/60 (Takizawa, 2009). Multiple bodily systems were affected by the 
poisoning: the kidneys were the most commonly affected organ (e.g., polyuria and 
polydipsia), the CNS was damaged irrespective of poisoning severity (e.g., 
coordination disturbances, visual impairments, disturbance of speech and tremors), 
generalised deep skeletal pain (including fasciculation and coarse twitching of 
muscles and myoidema), skin lesions (pruritus, exfoliative dermatitis in severe 
cases), and mild gastrointestinal symptoms were also commonly reported symptoms. 
In severe poisoning cases there was cardiac involvement (Jalili & Abbasi, 1961). 
While children were among those harmed during these two incidents, the literature 
does not identify in what ways, if any, that children were differentially affected to 
adults. Nor does the literature discuss whether there were implications to children in 
utero who were exposed through the consumption of wheat by the pregnant mother.   
Three events, occurring within two decades of each other, were critical in 
shaping our understanding of the impact that MeHg has on human health. Two 
outbreaks of MeHg poisoning caused by anthropogenic means occurred in the 
Kumamoto and Niigata Prefectures of Japan in 1956 and 1965 respectively. 
Minamata Bay, in the Kumamoto Prefecture, was contaminated by Hg released in the 
wastewater from an acetaldehyde chemical plant factory owned and operated by the 
Chisso Corporation. During this period of time, Minamata City was an area largely 
populated by relatively poor fishing villages and it was common practice for the 
fishermen supplement the diet of their family with fish and shellfish caught from 
Minamata Bay. In 1956, a 5-year old girl presenting to the Chisso Corporation’s 
Minamata factory hospital became the first recognized case of MeHg poisoning, 
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although it was not proven until 1959 (Harada, 1997). The Minamata Bay disaster 
gave rise to two conditions, Minamata disease and Congenital Minamata disease. 
Minamata disease (essentially MeHg poisoning) caused severe damage to the 
CNS, resulting in a range of neurological symptoms of which the most common were 
disturbance of sensation and coordination, visual and hearing impairments, tremor, 
dysarthria and mental disturbances (Harada, 1997, Uchino et al., 1995). Congenital 
Minamata disease was the result of MeHg crossing the placental barrier in pregnant 
women who had consumed the contaminated seafood. Many of these children were 
born with cerebral palsy, cerebral palsy-like features (e.g., microcephaly, 
hyperreflexia, gross motor and mental impairment) or other deformities, while in 
most cases, the mother remained largely unaffected from the toxic effects of Hg
(Harada, 1968, 1995). A similar episode of MeHg poisoning occurred shortly after in 
1965 in the Niigata Prefecture of Japan where again Hg was released in the 
wastewater of an acetaldehyde chemical plant this time owned by the Showa 
Electrical Company (Lofroth, 1978).
In Iraq, a further mass MeHg poisoning outbreak occurred in 1971/2 similar in 
nature to the ethylmercury incidents witnessed only two decades prior. Following 
poor wheat harvests in Iraq, wheat was imported from Mexico and in order to protect 
it during the long transport, MeHg was used as a form of fungicide. While the wheat 
was distributed to farmers for planting (as opposed to consumption), the cause of the 
outbreak was traced to the ingestion of seed wheat that had been ground into flour to 
make bread. Reportedly over 6,500 people were hospitalised, of which 459 died 
(Bakir et al., 1973). These figures are considered conservative as many families 
chose not to take their sick family members to the hospital (or discharged them from 
hospital) upon learning that there was no cure. As with the incident in Minamata, 
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children exposed during infancy and in utero were profoundly affected with highly 
similar symptoms including cerebral palsy, altered muscle tone and deep tendon 
reflexes, and delayed developmental milestones (Amin-Zaki et al., 1974, 1979; Bakir 
et al. 1973; Rustam & Hamdi, 1974).
The financial consequences of MeHg toxicity are considerable. It has been 
calculated that the costs to children exposed to MeHg in utero, based on cord-blood 
coQFHQWUDWLRQVȝJ/HTXDWHVWRDSSUR[LPDWHO\86ELOOLRQSHUDQQXP7KH
cost is estimated on the basis of loss of productivity as a direct consequence of loss 
of IQ due to MeHg toxicity (Trasande, Landrigan & Schechter, 2005)
Diet
Fish and shellfish are a rich source of protein, omega-3 fatty acids, vitamins A 
and D and iodine and are therefore highly recommended as part of a healthy well-
balanced diet (Weichselbaum, Coe, Buttriss & Stanner, 2013). The safe level for 
seafood consumption (2-3 serves, approximately 75-150 grams per serve) was 
established from a study of children in the Seychelle Islands (Myers et al., 2003). As 
no adverse neurodevelopmental effects from prenatal MeHg exposure were detected, 
the mean exposure in the study was selected as the no-observed-adverse-effect level 
(NOAEL). Although it has been argued that the methodology employed to determine 
the safe level may not provide the best indicator of a no-effect exposure level 
(Crump et al., 2000). Furthermore, the safe level recommended for women who are 
pregnant or nursing may be set too high (Brown & Austin, 2012).
The effects of a diet high in concentrations of MeHg (due to seafood 
consumption) to the unborn or newborn child via the placenta and breast milk have 
been well-documented, indeed it has been reported by the National Academy of 
Sciences that seafood consumption during pregnancy is the most important and best-
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studied end-point for MeHg poisoning (National Research Council, 2000). For 
example, the concentration of Hg in the pregnant mother’s cord blood has been 
shown to positively increase with the amount of seafood consumed during pregnancy 
(Bjornberg et al., 2003). Likewise, studies have found the concentration of Hg in 
breast milk to have a significant positive correlation with the amount of fish and 
shellfish consumed during lactation (Chien et al., 2006; Drasch, Schupp, Hofl, 
Reinke & Roider, 1994; Drexler & Schaller, 1998). 
Neurodevelopmental problems associated with seafood consumption have also 
been identified. A prospective study on a cohort of Faroese children exposed to 
MeHg in utero through their mother’s consumption of pilot whale meat identified 
neuropsychological deficits at 7-years of age (Grandjean et al., 1997) and irreversible 
impairment to areas of brain function at 14-years (Murata, Weihe, Budtz-Jørgensen, 
Jørgensen, & Grandjean, 2004). Furthermore, for pregnant women within the low 
exposure range, a positive association was identified between exposure level and 
developmental delay. Specifically, the developmental delay was extended by 1-2
months for each doubling of prenatal MeHg exposure level (Grandjean et al., 1997). 
A limitation that needs to be taken into consideration is the use of hair to provide a 
measure of Hg concentration in the Faroese studies. As identified by the authors, hair 
colour, treatment and growth rate, for example, may have potentially contaminated 
the results. A possible relationship between neurodevelopmental problems and 
infants fed fish congee as a weaning food (a common behaviour among some coastal 
communities in China and South East Asia) was also found among a small number of 
children presenting to a clinic in Sydney, Australia (Corbett & Poon, 2008). 
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Dental amalgam
Dental amalgam is a major source of elemental Hg exposure. Known also as 
silver fillings, dental amalgam have a long use in western dentistry, dating back to 
the 1830s, although its use in recent years has been declining in some counties such 
as the UK and US, whereas in others (e.g., Norway, Sweden, Denmark and Russia) 
its use has been banned altogether (United States Department of Health and Human 
Services [US DHHS], 1993). An amalgam is a metal alloy and is comprised of 
elemental Hg in the range of 45-55% (Ferracane, 2001). Once an amalgam is placed, 
Hg is continually released in the form of vapour, ions and particles throughout the 
life of the filling. Furthermore, the release of vapour is stimulated by ordinary, 
everyday activities, such as chewing gum, eating, brushing teeth and drinking hot 
fluids, in addition to habitual behaviours like bruxism (teeth grinding) (Svare et al, 
1981, Barregård, Sällsten & Jarvholm, 1995). For example, there was a 3.5-fold 
increase ȝJOLWUHWRȝJOLWUHEHIRUHDQGDIWHUFKHZLQJLQWKHDYHUDJHVDOLYDU\
Hg level of 108 people with dental amalgam (Bjorkman, Sandborgh-Englund & 
Ekstrand, 1997). 
In the general, non-occupationally exposed population, dental amalgam is the 
principal source of Hg exposure, exceeding that of seafood or industrial-related 
processes (Skare, 1995). Approximately 70-80% of inhaled Hg vapour is absorbed in 
the blood through the lungs, however, Hg vapour entering through the nose 
following exhalation can also be found in sections of the brain (e.g., olfactory lobe 
and tract, pituitary gland) (Stock, 1935). Both human and animal studies have 
demonstrated that dental amalgam makes a significant contribution to Hg body 
burden (World Health Organization [WHO], 1991; US DHHS, 1993; Weiner & 
Nylander, 1995).
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Foetuses and infants are also at risk of elemental Hg exposure through maternal 
amalgam. Hg released from dental amalgam fillings can pass through the placenta 
and breast milk accumulating in the child’s tissues (Vimy, Hooper, King & 
Lorscheider, 1997). Animal studies have shown that Hg from amalgam fillings can 
impact the foetal liver, kidney and brain and transfer to breast milk in detectable 
amounts (Takahashi, Tsuruta, Hasegawa, Kameyama & Yoshida, 2001; Vimy,
Takahashi & Lorscheider, 1990). Concentrations of Hg in the colostrum and breast 
milk of women collected within four weeks following birth have been found to 
significantly correlate with the number of amalgam fillings (da Costa, Malm & 
Dórea, 2005; Drasch, Aigner, Roider, Staiger & Lipowsky, 1998; Drexler &
Schaller, 1998). While it appears that the concentration of Hg in breast milk declines 
over time (Drexler & Schaller, 1998), da Costa et al. reported that the amount of Hg 
transferred to the infant via breast milk was above the WHO reference for more than 
half of the women in their sample. Cord blood concentrations of Hg have also shown 
a positive correlation with the number of maternal amalgams (Björnberg et al., 
2003). Furthermore, Hg concentrations in the kidneys of infants reportedly increase 
according to the number of maternal fillings (Drasch et al., 1994; Drasch & Roider,
1995). Interestingly, a study by Drasch et al. (1998) found the Hg concentration of 
formula milk samples (reconstituted with Hg-free water) were equivalent to mothers 
who fell in the mid-range of amalgam fillings (1-7 fillings), suggesting, based on Hg 
exposure alone, that it is safer for a child to be formula fed if a mother has more than 
seven dental fillings. Nevertheless, not all studies have found a significant correlation 
between maternal amalgam surfaces and concentration of Hg in the breast milk 
(Klemann et al., 1990).
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There is a paucity of studies investigating the long-term effects of exposure to 
maternal amalgam in utero and during infancy. Some studies suggest there are no 
ensuing neurodevelopmental or neuropsychological effects (Bellinger, Daniel, 
Trachtenberg, Tavares & McKinlay, 2007; Watson et al., 2013), although a case-
control study conducted in Norway indicates that dental work may be associated with 
cleft palate. Preliminary results of the study, presented at the University of Southern 
Denmark, found that the odds of giving birth to a child with cleft palate quadrupled 
for women who had restorative work in the first two months of pregnancy. 
Furthermore, greater odds of cleft palate were associated with undergoing multiple 
procedures in the first trimester (DeRoos, 2011).    
Vaccinations
The reduction of once prevalent childhood diseases such as measles, mumps, 
rubella, diphtheria and polio are attributed to the development of vaccines and 
nationalised vaccine programs (Ehreth, 2003). Nonetheless, the safety of vaccines 
remains a keenly debated issue particularly in relation to ASD. 
Two divergent theories suggesting an association between vaccines and ASD 
have been especially prominent in the past couple of decades. The first of the two 
came to prominence following the now retracted publication of a paper by Wakefield 
et al. (1998) in the eminent journal The Lancet. The authors found intestinal 
abnormalities in a small group of children (n=12) who had been diagnosed with a 
regressive form of ASD, that is, the children had developed normally before 
suddenly losing acquired skills, including communication. The cause of the intense 
scrutiny of both the paper and authors was the inclusion in the findings that the onset 
of behavioural symptoms for 8 of the 12 children was reported by parents to be 
associated with the measles-mumps-rubella (MMR) vaccine. 
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The second of the two theories, which is pertinent to this thesis, suggests that 
there is an association between the preservative thiomersal (also known as thimerosal 
and merthiolate) and ASD. Developed in 1937, thiomersal (sodium 
ethylmercurithiosalicylate) is 49.55% ethylmercury by weight and has been used as a 
preservative in vaccines since the 1930s to maintain sterility and extend shelf-life, 
particularly in multi-dose vials (Tan & Parkin, 2000). Upon entering the body, 
thiomersal is metabolised to ethylmercury and then into inorganic Hg compounds 
(Qvarnström, Lambertsson, Havarinasab, Hultman & Frech, 2003). Concern has 
been raised that infants are receiving doses of Hg that may exceed safe levels due to 
the amount of thiomersal-containing vaccines (TCVs) received in the first few years 
of life. These concerns are not without justification. It is stated in the Australian 
Immunisation Handbook (Australian Technical Advisory Group on Immunisation
[ATAGI], 2008) that “the possibility existed that vaccination of newborn babies,
particularly those of very low birth weight, with repeated doses of thiomersal-
containing vaccines, might have resulted in levels of mercury above the 
recommended guidelines” (p.355). Indeed, following the administration of TCVs, 
significant amounts of Hg has been measured in the blood and hair of infants 
(Stajich, Lopez, Harry & Sexson, 2000; Pichichero et al., 2008, 2009; Marques,
Dórea, Bastos & Malm, 2007). Furthermore, body mass and developmental maturity
was critical with premature infants reported to accumulate >3 times the level of 
blood Hg in contrast to other infants. For example, Stajich et al. (2000) found mean 
levels of Hg among pre-term babies to increase from .54μg/L to 7.36μg/L post-
vaccination. Mean Hg levels among at-term babies increased .04μg/L to 2.24.μg/L.
A number of recent epidemiological and ecological studies have reported a 
significant association between TCVs and neurodevelopmental disorders, including 
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autism, speech disorders, mental retardation, thinking abnormalities, deficits in 
psychomotor development and infantile spasms (Gallagher & Goodman, 2008, 2010; 
Geier & Geier, 2003a, 2003b, 2003c, 2004, 2005, 2006b, 2006c, 2006d, 2006e, 
2006f; Mrozek-Budzyn, Majewska, Kieltyka & Augustyniak, 2012; Young, Geier, & 
Geier, 2008). Adverse neurodevelopmental consequences have also been found in a 
number of animal studies on rats, mice and monkeys designed to mirror the 
paediatric US vaccination schedule (Hornig, Chian & Lipkin, 2004; Ida-Eto et al., 
2013; Olczak, Duszczyk, Mierzejewski, Meyza & Majewska, 2011; Sulkowski, 
Chen, Midha, Zavacki & Sajdel-Sulkowska, 2012; Hewitson et al., 2010; Hewitson,
Lopresti, Stott, Mason & Tomko, 2010). Furthermore, Burbacher et al. (2005) found 
monkeys injected with TCVs to have a higher average brain-to-blood concentration 
ratio than MeHg-exposed monkeys, 3.5 ± 0.5 in comparison to 2.5 ± 0.3. However, it 
is important to take into consideration researcher bias, whether intentional or 
unintentional, on study outcomes. For example, the Geiers’ have published many 
studies finding evidence against the use of vaccinations and Hg, but they are also 
well-known advocates against the use of Hg and are funded by like-minded 
individuals and groups with strong political activity in this area.
Not all studies have found an association between TCVs and 
neurodevelopmental disorders, in particular ASD (Andrews, Miller, Grant, Stowe, 
Osborne & Taylor, 2004; Fombonne, Zakarian, Bennett, Meng & McLean-Heywood, 
2006; Hviid, Stellfeld, Wohlfahrt & Melbye, 2003; Madsen et al. 2003; Stehr-Green, 
Tull, Stellfeld, Mortenson & Simpson, 2003). A further study by Verstraeten et al. 
(2003) was inconclusive. More than 5000 cases have been filed for autism-related 
injuries as a result of vaccination to the US Court of Federal Claims, typically 
referred to as the Vaccine Court (Keelan & Wilson, 2011). Of these, six test cases
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that purported a link between autism and vaccines (three of which specifically cited 
Hg as the causative agent) were heard by the Vaccine Court to ascertain whether 
there was any validity to the claim of a link, and ultimately whether any further cases 
would be heard. In 2010, the final of the six cases (Cedillo v. DHHS) came to a 
conclusion, the ruling stated that the claimant had failed to present a viable theory of 
how autism could be caused by vaccines on a personal or more general level 
(Haertlein, 2012). 
Currently there is not enough evidence to support or refute a link between 
vaccines and ASD. While thiomersal was phased out from 1999 in the US and 2000 
in Australia (National Centre for Immunisation Research and Surveillance of 
Vaccine Preventable Diseases, 2007; ATAGI, 2008), it is still used in developing 
countries (Dórea, Marques & Brandao, 2009), in inactivated influenza vaccines in 
the US (which may be administered to pregnant women and infants), and in multi-
dose vials in Canada and the US (CDC, 2012; Public Health Agency of Canada, 
2011). Indeed, surprisingly in the face of existing evidence, the United Nations 
Minamata Convention on Hg, whose primary objective is to protect human health 
from exposure to Hg and Hg compounds, exempted TCVs from regulation (Sykes et 
al., 2014)`. 
Pollution
According to the United Nations Environmental Programme (UNEP) (2002), 
approximately 70% of elemental Hg is released into the atmosphere through 
anthropogenic means, such as the combustion of fossil fuels via power plants, 
chloralkali production, and waste incineration. Through combustion, Hg present in 
fossil fuels is thermally converted into elemental Hg vapour which readily becomes 
airborne, travelling long distances until the particles ultimately deposit in the soil and 
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water (Galbreath & Zygarlicke, 1996). In recent years, there has been a growing 
body of research investigating possible associations in pre- and postnatal exposure to 
ambient levels of air pollution (due to power plants, traffic and urbanisation) with 
adverse neurodevelopmental outcomes.
An ecological study by Palmer, Blanchard, Stein, Mandell and Miller (2006) 
investigated whether environmentally released Hg (based on data from the US 
Environmental Protection Agency [EPA] Toxic Release Inventory [TRI]) was 
associated with autism prevalence and special education services among 254 
counties and 1184 school districts in Texas. The authors reported a 61% increase in 
autism prevalence and 43% increase in special education services for every 1000 
pounds of environmentally released Hg. A further ecological study by Palmer,
Blanchard and Wood (2009) found Hg emissions from coal-burning power plants in 
1998 to be significantly associated with autism prevalence in 2002. In addition, a 
decrease in autism cases was correlated with increased distance from the source of 
the emissions. However, the use of TRI data in both Palmer et al. studies has been 
criticised. Lewandowski, Bartell, Yager and Levin (2009) suggest that TRI data may 
not reflect concentrations of toxic substances in the immediate environment. 
Furthermore they question whether the use of TRI data allows a causal relationship 
to be established, that is, whether it can be proven that exposure to Hg preceded a 
diagnosis of ASD. Consequently, Lewandowski et al. conducted a replication study 
to assess the robustness of TRI. The study investigated TRI Hg emissions data in the 
same Texan counties and school districts reported by Palmer et al. (2006); however 
the emissions data was analysed for different years. The study failed to replicate the 
findings reported in the Palmer et al. studies.
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Several studies have reported a positive correlation between airborne Hg and 
ASD prevalence rates and ASD risk. For example, in San Francisco Bay, areas with 
concentrations of atmospheric Hg in the highest quartile (based on data from the US 
EPA) were found to have a significantly higher ASD prevalence rate than areas with 
concentrations of atmospheric Hg in the lowest quartile (Windham, Zhang, Gunier, 
Croen & Grether, 2006). The study was strengthened by its ability to identify and 
confirm cases. However, a notable limitation to this study was the failure to take into 
consideration other sources of toxic exposure, including diet, occupation and 
smoking. 
Roberts et al. (2013) found perinatal exposure to air pollutants had a 
significant positive linear trend with risk of ASD for Hg (in addition to other heavy 
metals). Guxen et al. (2012) also found residential air pollution in Spain to adversely 
affect infant mental development. Interestingly, antioxidant intake (e.g., maternal 
consumption of fruits and vegetables) appeared to mediate the adverse effect of air 
pollutants on neurodevelopment, but not in Gipuzkoa, a highly industrialised region 
of Spain. 
In addition to power plants, traffic-heavy locations appear to make a substantial 
contribution to air pollution. Volk, Hertz-Picciotto, Delwiche, Lurmann and 
McConnell (2011) found autism to be associated with pregnant women residing 
within 310 meters of heavy traffic (via freeways and major roadways) during their 
third trimester (OR = 2.22; 95% CI, 1.16–4.42) and at the time of delivery (OR = 
1.86; 95% CI, 1.04–3.45). Becerra, Wilhelm, Olsen, Cockburn and Ritz (2013) also 
found an association between exposure to traffic-related air pollution during 
pregnancy and autism. The authors employed a land use regression model based on 
data from air monitoring stations to estimate Hg exposure. Lai, Tseng, Hou and Guo 
An investigation of the potential association between mercury and ASD        63
(2012) found ASD prevalence rates to be higher in urban areas of Taiwan than rural 
areas. One reason suggested by the authors for the difference in prevalence rates was 
that urbanisation may be associated with increased levels of hazardous air pollutants. 
It is also likely that urbanisation is associated with increased levels of traffic, which 
as noted above, has been associated with autism.
Not all studies have found Hg air pollutants to be associated with deficits in 
neurodevelopment. Tang et al. (2008) investigated whether child development was 
adversely affected by prenatal exposure to pollutants from a seasonally operated coal 
power plant in Tongliang, a county of Chongqing, China. The power plant is 
responsible for approximately 46% of Chongqing’s total Hg emissions. Tang et al. 
measured levels of polycyclic aromatic hydrocarbons (PAH) – DNA adducts and 
concentrations of lead and Hg in umbilical cord blood. The results of the study 
showed that children were adversely affected by exposure to pollutants at 2 years of 
age as measured by motor, adaptive, language, and social development quotients. 
However, while a reduction in one or more of the developmental quotients was 
significantly associated with PAH-DNA adducts and concentrations of lead in the 
cord blood, no such association was found with Hg. Some limitations with the study 
were noted by the authors, with perhaps the most critical limitation being that they 
did not collect postnatal blood PAH-DNA, lead or Hg levels. Therefore, postnatal 
exposure could not be compared against the cognitive development of the sample at 
two years of age. Dórea (2008) identified a possible methodological flaw beyond 
those discussed by Tang et al.’s study, raising the issue that uncontrolled sources of
Hg, namely TCV and MeHg in food sources other than fish (particularly rice) were 
not accounted for in the analysis.
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Genetics
Which genes an individual inherits plays a crucial role in detoxifying the body 
of Hg. Apolipoprotein E (APOE) is a major protein transporter expressed in the brain 
and is a known mediating factor in neuronal repair (Buttini et al., 1999; Mahley, 
1988). There are three genetic variants of APOE: APOE2, APOE3 and APOE4. 
APOE consists of 299 amino acids with different ratios of cysteine and arginine at 
positions 112 and 158. Cysteine, unlike arginine, contains a sulfhydryl group which 
can bind, and importantly detoxify heavy metals (including Hg) in the nerve cell.
APOE2 contains two cysteines and APOE3 contains one cysteine and one arginine, 
whereas APOE4 contains two arginines (Pendergrass, Hayley, Vimy, Winfield & 
Lorscheider, 1997; Mahley, 1988). Therefore, individuals who inherit at least one 
APOE4 are likely at greater risk of heavy metal accumulation in brain tissue and as 
such at greater risk of developing heavy metal induced neurological diseases and 
neurodevelopmental behaviours (Godfrey, Wojcik & Krone, 2003; Ng et al., 2013; 
Stewart, Schwartz, Simon, Kelsey & Todd, 2002). There is some suggestion that 
individuals diagnosed with autism may have a reduced capacity to excrete Hg due to 
inheriting at least one APOE3 or APOE4. For example, Giunco et al (2009) found 
APOE2 and APOE4 to be more prevalent among a sample of individuals with 
autism. Other studies however, have failed to find an association between APOE and 
autism (e.g., Raiford et al., 2004).
Mercury and Autism
Mutter et al. (2005) reported that in the US, infants have been exposed to levels 
of Hg substantially higher than US federal safety guidelines. In 2001, a paper 
published in the journal Medical Hypotheses by Bernard et al. drew parallels between 
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the symptomatology of Hg toxicity and ASD (e.g., mental retardation, loss of speech, 
social withdrawal) suggesting that ASD is a form of Hg poisoning. Later studies 
appear to support this assertion identifying a number of biological irregularities 
common among children with ASD that are consistent with Hg toxicity, such as, 
elevated oxidative stress (e.g., James, et al., 2004; Kern & Jones, 2006), immune 
dysfunction (e.g., Cohly & Panja, 2005), neural and generalised inflammation (e.g., 
Herbert, 2005; Pardo, Vargas & Zimmerman, 2005; Vargas, Nascimbene, Krishnan, 
Zimmerman & Pardo, 2005; Zimmerman et al., 2005) and depleted glutathione levels 
(e.g., James et al., 2004).
The paper by Bernard et al. has become the cornerstone of the Hg-autism 
hypothesis which postulates that ASD develops due to an interaction between a 
genetic susceptibility and environmental trigger. Essentially, the Hg-autism 
hypothesis is a two-part hypothesis that states that a child needs to have a 
predisposing genetic sensitivity to Hg in conjunction with being exposed to Hg for 
ASD to develop. Exposure may be chronic or acute and occur either in utero or 
during infancy. 
Mercury can be measured in a number of different ways, most commonly in 
the hair, blood or urine, although Hg has also been measured in the teeth, finger/toe 
nails, faeces, and brain. Before considering ASD studies specifically, it is perhaps 
first important to note that the method of measuring Hg greatly influences the 
interpretation of results. For example, the half-life of Hg in the blood is relatively 
short with an initial half-life of 1-3 days followed by a slower phase half-life of 1-3
weeks (Barregård et al., 1992), or perhaps several weeks longer in the case of chronic 
exposure (Sallsten, Barregård & Schütz , 1993). As such, blood Hg can be a useful 
measure of recent or ongoing exposure but is not an ideal measure of past exposure. 
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In contrast, concentrations of Hg in the hair provide a better measure of past 
exposure than blood Hg. Depending on the biological test conducted, measuring Hg 
in urine can provide: (1) a measure of total urinary Hg concentration, (2) a biological 
marker of Hg damage (via porphyrins), or (3) a measure of Hg body burden (via 
provoked urine challenge). Elevations in porphyrin levels indicate that enzymes in 
the biosynthesis pathway have been impaired due to the toxic effects of heavy 
metals. Elevations in the urinary levels of pentacoproporphyrin (5CP), 
precoproporphyrin (PrCP), and coproporphyrin (CP) are specifically associated with 
Hg exposure (Heyer, Bittner, Echeverria & Woods, 2006; Woods et al., 2005). A 
provoked urine challenge involves administering a chelating agent (e.g., 2,3-
dimercapto-1-propanesulfonic acid [DMPS]; dimercaptosuccinic acid [DMSA] or 
ethylenediaminetetraacetic acid [EDTA]) orally, intravenously or as a suppository. 
The chelating agent binds to Hg (and other metals) circulating in the blood and 
organs, particularly the kidneys, which is then rapidly excreted in the urine, from 
where Hg concentration is measured (Ruha, 2013).
The number of studies investigating Hg and ASD has steadily grown since the 
paper by Bernard et al., however, the results have been inconsistent. Table 5 presents 
a list of Hg and ASD studies conducted in recent years reporting measurements of 
Hg in the blood, hair or urine. 
Whether an end-point of Hg exposure includes ASD remains a topic of intense 
debate. While the mounting evidence that Hg is associated with ASD is compelling, 
the evidence is not definitive. More research addressing this potential association is 
critical. It is therefore the intention of this thesis to apply an interdisciplinary 
approach to explore the question of whether a relationship exists between Hg and 
ASD. Specifically, a biological and hereditary approach will be taken. Urinary 
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porphyrins have been selected as the primary biological outcome measure. There are 
two key reasons for this decision. First, the process of collecting urine for porphyrin 
analysis is non-invasive and reasonably low-stress, which is essential for vulnerable 
populations, such as children with ASD. Urine collection is conducted at home, 
which can be easier on the child and allows the parent to have some control over the 
process. They can choose which day collection will occur and prepare their child 
over a period of days if necessary. Second, porphyrins provide a measure of Hg 
damage as opposed to the current level or concentration of Hg. Therefore, when the 
exposure occurred is not as critical as it would be should Hg be measured in the 
blood for example.
In the following chapters, three published studies will be presented. The first 
study (Chapter 4) will determine whether the porphyrin profiles of an Australian 
sample of children with a diagnosis of ASD exhibit elevated urinary porphyrin levels 
that reflect a pattern of Hg damage. This will be a pilot study, the results of which 
will determine whether a further study is warranted. The second study (Chapter 5) 
will address the limitations of the pilot study and expand upon previously published 
porphyrin studies. A larger sample will be recruited, in addition to recruiting two 
normally developing, healthy control groups (sibling control and external control).
Furthermore, the study will determine whether group membership and ASD severity 
can be predicted using porphyrin profiles. The final study (Chapter 6) will examine 
individual susceptibility to Hg by determining the ASD prevalence among the 
descendants of a cohort of the general population with a known sensitivity to Hg 
(pink disease survivors). 
Table 5
Studies examining Hg levels (blood, hair, urine) among children with ASD
Measure Author/s Publication 
year
Results
Blood Adams et al. 2013 Failed to find a significant difference in Hg levels in whole blood or red blood cells between ASD and control 
groups. However, regression analysis showed Hg levels in whole blood and red blood cells to be consistently 
significant with autism severity
Albizzati et al. 2012 Failed to find a significant difference in whole blood Hg concentration between ASD and controls
DeSoto & Hitlan1 2007 Significant relationship between Hg whole blood levels and diagnosis of ASD
Geier et al. 2010 Significantly higher Hg levels in red blood cells among ASD group compared to controls
Hertz-Picciotto et al. 2010 Failed to find a significant difference in whole blood Hg levels between ASD and controls
Rahbar et al. 2012 Failed to find a significant difference in whole blood Hg concentrations between ASD and controls
Stamova et al. 2011 Failed to find a significant difference in whole blood Hg between boys with ASD and control
Hair Adams et al.2 2008 ASD group 2.5-fold more likely to have lower hair Hg levels compared to matched controls
Adams et al. 2006 Failed to find a significant difference in hair Hg levels between ASD and controls
Al-Ayadhi 2005 Significantly higher hair Hg levels among ASD group compared to controls 
Albizzati et al. 2012 Failed to find a significant difference in hair Hg levels between ASD and controls
Blaurock-Busch et al. 2011 Failed to find a significant difference in hair Hg levels between ASD and controls
Blaurock-Busch et al. 2012 Hair Hg levels significantly higher among ASD group compared to controls. Significant positive correlation 
between Hg and object use and auditory response
De Palma et al, 2012 Failed to find a significant difference in hair Hg levels between ASD and controls
El-baz et al. 2010 Significantly higher hair Hg levels among ASD group compared to controls. Failed to find significant 
difference in hair Hg levels across IQ groups, although Hg levels highest in most disabled group
Fido & Al-Saad 2005 Boys with ASD had significantly higher hair Hg concentrations in comparison to matched controls
Geier et al. 2012 Significant positive correlation between hair Hg concentrations and ASD severity
Holmes et al.2 2003 Hair Hg levels significantly lower in ASD group compared to controls. Negative correlation between hair Hg 
level and ASD severity
Kern et al. 2007 Failed to find a significant difference in hair Hg levels between ASD and matched controls
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Table 6 cont.
Measure Author/s Publication 
year
Results
Hair Majewska et al. 2010 Significant difference between ASD groups and controls – younger ASD group (3-4yrs) lower hair Hg levels 
than controls, older ASD group (7-9yrs) higher hair Hg levels than controls
Priya & Geetha 2011 Significantly higher hair Hg levels in ASD group compared to controls. Elevation of Hg more pronounced 
among low functioning autism group in contrast to moderate and high functioning autism groups
Williams et al. 2008 Failed to find a significant difference in hair Hg levels between ASD group and controls
Teeth Adams et al. 2007 Significant difference between ASD and control group. Hg levels in the baby teeth of the ASD group higher 
than the control group. Use of oral antibiotics discussed as a potential confounder 
Urine
Total Hg 
concentration Adams et al. 2013 Failed to find a significant difference in urinary Hg concentration between ASD and controls
Albizzati et al. 2012 Failed to find a significant difference in urinary Hg concentration between ASD and controls
Blaurock-Busch et al. 2011 Significant difference in mean urinary Hg levels between ASD and controls
Wright et al. 2012 Failed to find significant difference in urinary Hg (corrected for creatinine) levels between children with ASD 
and 3 control groups (mainstream schoolchildren, children from special schools & ASD siblings)
Porphyrins Geier & Geier 2006b Median CP levels of unchelated ASD group significantly higher than sibling control. No significant 
difference found between chelated ASD group and sibling control
Geier & Geier 2007 Supported results of 2006 study (above). Unchelated ASD group significantly higher urinary 5CP levels in 
comparison to chelated group and sibling control. Unchelated ASD group had higher elevations in PrCP and 
CP relative to general population control. 
Nataf et al. 2006 Elevated levels of 7CP, 6CP, 5CP, PrCP and CP among children diagnosed with autistic disorder relative to 
controls. Positive correlation between porphyrin levels and ASD severity.
Chelation Bradstreet et al. 2003 (DMSA administered) ASD group excreted Hg at 3-6 times the level of neurotypical children 
Soden et al. 2007 (DMSA administered) Failed to find increased urinary Hg levels between ASD group and controls 
1Reanalysis of dataset analysed by Ip et al. (2004); 2Hair taken from infants (12-24mths). All other studies analysed hair from young children and in some cases teenagers 
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Chapter 4: An investigation of porphyrinuria in Australian children with 
Autism.
In order to establish whether a relationship between Hg and ASD potentially 
exists, it was first necessary to determine whether there was evidence of Hg toxicity 
among a small convenience sample of Australian children diagnosed with ASD. The 
results of urinary porphyrin profiles were analysed to establish whether this was the 
case.
Urinary porphyrins are a non-invasive method of measuring general xenobiotic 
exposure (Brewster, 1988) and Hg exposure specifically (Heyer et al., 2006; Woods 
et al., 2005). Porphyrinuria, the excessive excretion of porphyrins, develops due to a 
disruption of enzymes in the heme biosynthesis pathway (see Figure 1). The steps in 
the pathway most vulnerable to heavy metal disruption involve uroporphyrin 
decarboxylase (UROD) (Woods & Kardish, 1983) and coproporphyrinogen oxidase 
(CPOX) (Woods et al., 2005). Inhibition to the CPOX and UROD enzymes cause 
elevations of urinary coproporphyrin (CP) and pentacarboxyporphyrin (5CP). The 
atypical porphyrin keto-isocoproporphyrin, more commonly known as 
precoproporphyrin (PrCP), produced by in vivo conversion of 5CP in the presence of 
heavy metal, has been specifically associated with Hg exposure (Heyer et al., 2006; 
Woods et al., 2005).
Urinary porphyrins have been recognized as an essential measure of Hg
toxicity. In 2006 the first biennial meeting of the Hg bioindicators roundtable was 
held with the purpose of identifying a set of reliable tools for measuring Hg toxicity 
over a period of time for developed and developing countries and across species 
(humans, wildlife, and rodents). A key recommendation from the committee 
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was that further porphyrin studies be conducted so as to evaluate PrCP (Henshel et 
al., 2007). 
Three studies, one conducted in France (Nataf et al., 2006) and two in the US 
(Geier & Geier, 2006d, 2007), set the precedence for this study. Nataf et al., the first 
team to investigate porphyrins and autism, observed a porphyrin pattern among 
French children with Autistic Disorder (AUT) that implicated Hg toxicity. In a 
sample of 269 French children aged 2-15 years, the researchers found elevated levels 
of heptacoproporphyrin (7CP), hexacoproporphyrin (6CP), 5CP, PrCP, and CP 
among children diagnosed with AUT (n=106) (and AUT + epilepsy, n=9) relative to 
an internal and external control group. It is important to be cautious interpreting the 
results in light of the limitations of the study, namely, the small internal control 
group (n=12) and the comparison to an external group from another country 
(Switzerland). Subsequently Geier and Geier (2006d, 2007) replicated these findings 
in two small studies in the US. The researchers first investigated the difference in 
Figure 1
Figure 1. Pathway of heme biosynthesis, 
major urinary metabolites, and inhibition 
by heavy metals. Porphyrinogens appear 
in urine as porphyrin derivatives (right): 
urinary 5CP, PrCP, and CP are indicators 
of inhibition of UROD and/or CPOX; 
urinary UP is not reported to alter with 
inhibition of these enzymatic steps. 7-
carboxy, 6-carboxy; 7CP, 6CP; hepta-
and hexa-carboxyporphyrinogens and –
carboxyporphyrins, respectively. 
(Reprinted with permission from 
“Porphyrinuria in childhood autistic 
disorder: Implications for environmental 
toxicity,” by R Nataf et al., 2006, 
Toxicology and Applied Pharmacology, 
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urinary CP levels among chelated and unchelated individuals diagnosed with ASD 
(n=37, 7-22 years of age) in comparison to a neurotypical sibling control group (n=7, 
7-20 years of age). They found that the median CP levels of unchelated individuals 
with ASD were significantly higher than that of the control group, whereas no 
significant difference was found between chelated individuals with ASD and the 
control group (Geier & Geier, 2006d). An extension of this study by the same 
investigators (Geier & Geier, 2007) supported the results. Additionally, they found 
that unchelated individuals with ASD had significantly higher urinary 5CP levels in 
comparison to chelated individuals with ASD and to chelated individuals + sibling 
controls. Unchelated individuals with ASD also had higher elevations in both PrCP 
and CP (normalized to uroporphyrin) relative to the general population control.
The following paper reports on the first empirical study presented in this thesis.
A convenience sample of Australian children (N=41) with a diagnosis of ASD 
presenting to a clinical practice were recruited into the study. A pre-requisite of entry 
into the study was that the child had formerly undergone a urinary porphyrin test. 
The mean urinary porphyrin levels of this ASD group were then compared against 
the mean urinary porphyrin levels reported by Nataf et al. (2006) and Geier and 
Geier (2007) for their ASD and control groups. In addition, the porphyrin levels from 
all studies were compared to an external control group of normally developing
children (Minder & Schneider-Yin, 1996). 
The purpose of the study was to establish whether the porphyrin profiles of a 
sample of Australian children exhibit a pattern indicative of Hg damage. This is a
critical first study as no previously published studies have investigated Hg toxicity 
among a sample of Australian children diagnosed with ASD by using porphyrin 
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profiles (or by any other means). Furthermore, this study was designed as a pilot trial 
in order to determine whether a larger case-control study was warranted.
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Paper 2
Austin, D. & Shandley, K. (2008). An investigation of porphyrinuria in Australian 
children with Autism. Journal of Toxicology and Environmental Health, Part 
A, 71(20):1349-51.
Reprinted by permission of the publisher Taylor & Francis Ltd. 
http://informaworld.com
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Chapter 5: Are urinary porphyrins a valid diagnostic biomarker of Autism 
Spectrum Disorder?
The first empirical study presented in this thesis (Austin & Shandley, 2008) 
found support for the notion that there is a relationship between Hg and ASD. 
Therefore, a larger study using urinary porphyrin as the primary outcome measure 
was conducted. Critically, the study sought to address the limitations of the first 
study (small sample size, lack of appropriate comparison group) and extend upon 
existing porphyrin and ASD studies.
As discussed in Chapter 4, UROD and CPOX (steps in the heme biosynthesis 
pathway) are vulnerable to heavy metal disruption (Woods & Kardish, 1983; Woods 
et al., 2005). An elevation in three urinary porphyrins (5CP, CP and PrCP) have been 
associated with Hg toxicity, two of which are caused by an inhibition to the UROD 
and CPOX enzymes (5CP and CP) and the other produced by in vivo conversion of 
5CP in the presence of heavy metal (PrCP) (Heyer et al., 2006; Woods et al., 2005). 
In addition to providing a measure of Hg damage, a recent study by Heyer,
Echeverria and Woods (2012) demonstrated that urinary porphyrins (5CP and CP) 
have excellent predictive values in the detection of AUT and PDD-NOS. 
Furthermore, there is some evidence to suggest that urinary porphyrins may provide 
a marker of ASD severity (Nataf et al., 2006; Geier et al., 2009). 
The following paper investigated whether urinary porphyrin profiles could be 
used to: (1) detect ASD cases, and (2) predict ASD severity. Three groups of 
children aged 2-6 years were recruited: (a) children diagnosed with ASD, (b) siblings 
of children diagnosed with ASD (sibling control), and (c) children with no known 
blood relative diagnosed with ASD (external control). Participating families were 
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provided with a urinary collection kit (one per participating child) which included 
information on how to collect, store and ship the samples. The limitations of the first 
porphyrin study were addressed by recruiting a substantially larger sample and 
including two distinct healthy controls. Furthermore, this study extends upon 
previously published porphyrin studies by aligning with the DSM-5 nosology. That 
is, ASD was treated as a single dimension as opposed to using the former individual 
diagnostic groupings of Autistic Disorder, Asperger’s Disorder and PDD-NOS. In 
addition, a considerably younger and stricter age group was recruited for this study
(2-6 years).
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Paper 3
Shandley, K., Austin, D.W. & Bhowmik, J.L. (2014). Are urinary porphyrins a valid 
diagnostic biomarker of Autism Spectrum Disorder? Autism Research, 
7(5):535-42.
Reprinted by permission of the publisher John Wiley and Sons
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Chapter 6: Ancestry of Pink Disease (infantile acrodynia) identified as a risk 
factor for Autism Spectrum Disorders.
Contrary to expectation, the second empirical study presented in this thesis
(Shandley, Austin & Bhowmik, 2014) failed to find a difference between urinary 
porphyrins across three groups of children (ASD, sibling control, external control).
Furthermore, neither group membership nor ASD severity could be predicted based 
upon urinary porphyrins. Therefore, the final study will take a different approach to 
examine the potential association between Hg and ASD. The concept for this study is 
based on a component of the Hg-autism hypothesis which, as discussed earlier, 
postulates that ASD develops due to an interaction between a genetic susceptibility 
and environmental trigger. This study will investigate whether an individual 
susceptibility to Hg is heritable (and therefore genetic). To address this question, a
cohort of people with a known sensitivity to Hg, (survivors of pink disease) were 
surveyed to determine the prevalence of ASD among their descendants.
Pink disease, also known as infantile acrodynia, was an especially prevalent 
condition in Australia, North America, and Central Europe in the first half of the 20th
century (Rocaz, 1933). Two studies by Warkany and Hubbard (1948, 1951) led to 
the discovery that a form of inorganic Hg, calomel (mercurous chloride), widely used 
in teething powders, was responsible for the disease. Following the removal of this 
ingredient from most teething powders in the mid-1950s, pink disease essentially 
disappeared (Curtis, Ferguson, Kell & Samuel,. 1987). Critically, it was determined 
that merely being exposed to Hg was not sufficient for the disease to develop but, 
rather, an individual sensitivity to Hg must also be present (Bivings, 1949; Bivings & 
Lewis, 1948; Warkany & Hubbard, 1948).
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The following paper reports on the final study presented in this thesis. Pink 
disease survivors were surveyed (N=522) to obtain details of the clinical status of 
their children (n=1086) and grandchildren (n=1366). The prevalence rates of a range 
of clinical conditions (ASD, attention deficit/hyperactivity disorder, epilepsy, Fragile 
X syndrome and Down syndrome) was determined and compared to their respective 
general population prevalence rates (matched by year of birth).
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Paper 4
Shandley, K. & Austin, D.W. (2011). Ancestry of Pink Disease (infantile acrodynia) 
identified as a risk factor for autism spectrum disorders. Journal of Toxicology 
and Environmental Health, Part A. 74(18):1185-94.
Reprinted by permission of the publisher Taylor & Francis Ltd. 
http://informaworld.com
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Chapter 7: Discussion
ASD is a complex neurodevelopmental disorder and, although the pathogenesis 
of ASD is yet to be established, contemporary research indicates that an 
environmental trigger may play a critical role. Research investigating potential 
environmental triggers has accelerated in recent decades identifying a range of 
possibilities, including pesticides, pollution, chemicals, parental age, and maternal or 
neonatal infection. One proposed environmental trigger that has been the subject of 
considerable interest (and controversy) is that of Hg.
The mounting evidence that Hg is associated with ASD is compelling, but not 
definitive. Consequently, the question as to whether Hg is involved in the 
pathogenesis of ASD remains unanswered. More research addressing this potential 
association is critical. It was therefore the intention of this thesis to take a biological 
and hereditary approach to the question of whether a relationship exists between Hg 
and ASD. Three published studies were conducted. The first study (Chapter 4; 
Austin & Shandley, 2008) sought to establish whether the porphyrin profiles of a 
convenience sample of Australian children diagnosed with ASD reflected a pattern 
consistent with exposure to, and the toxic effects of, Hg (e.g., an elevation in urinary 
levels of 5CP, PrCP and CP). The second study (Chapter 5; Shandley, Austin & 
Bhowmik, 2014) sought to address the limitations of the first study (small sample 
size, lack of appropriate control group) and extend upon previous porphyrin studies 
by determining whether group membership and ASD severity could be predicted 
using porphyrin profiles. The final study (Chapter 6; Shandley & Austin, 2011) 
examined individual sensitivity to Hg by exploring ASD prevalence rates among the 
descendants of a cohort of the general population with a known sensitivity to Hg 
(pink disease survivors). 
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Urinary Porphyrins
Porphyrin profiles have been identified as a reliable tool for measuring Hg 
damage in humans, wildlife and rodents in both developed and developing countries
(Henshel et al., 2007). Furthermore, the process of collecting urine for porphyrin 
analysis is non-invasive and reasonably low-stress and therefore suitable for 
vulnerable populations, such as children with ASD. Two published studies in this 
thesis (Austin & Shandley, 2008; Shandley, Austin & Bhowmik, 2014) used urinary 
porphyrin profiles as the primary outcome measure. 
The first porphyrin study (Austin & Shandley, 2008) utilised a convenience 
sample of Australian children with ASD presenting to a psychology clinic that had 
formerly undergone porphyrin testing. The mean urinary porphyrin levels for this 
ASD group were compared against the mean urinary porphyrin levels reported by 
Nataf et al. (2006) and Geier and Geier (2007) for their ASD and control groups. In 
addition, the porphyrin levels from all studies were compared to an external control 
group of normally developing children (Minder & Schneider-Yin, 1996). The results 
of the study supported the hypothesis that the triad of porphyrins associated with Hg 
toxicity (5CP, PrCP and CP) among the Australian ASD group would be elevated in 
comparison to the control groups reported by the other three studies. Nevertheless, 
there were substantial limitations to this study including a small sample size, wide 
age-range and lack of control group matched for age and geographic location 
(country). The results, however, did indicate that a larger, controlled urinary 
porphyrin study was warranted.
The second larger porphyrin study presented in this thesis (Shandley et al. 
2014) compared a group of Australian children 2-6 years of age diagnosed with ASD 
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against two healthy control groups; a sibling control (children with a sibling 
diagnosed with ASD) and an external control (children with no known blood 
relatives diagnosed with ASD). In contrast to the first study, and indeed all known 
urinary porphyrin and ASD studies previously published (Austin & Shandley, 2008; 
Nataf et al., 2006; Geier & Geier, 2006d, 2007; Heyer et al., 2012; Kern et al., 2011; 
Woods et al., 2010; Youn et al., 2010), the hypothesis that there would be a 
significant difference in the urinary porphyrin levels between the ASD group and 
control groups was not supported. Furthermore, neither group membership, nor ASD 
severity could be predicted based upon urinary porphyrins. Essentially, the results do 
not support that there is an association between Hg and ASD. Nevertheless, there are 
several other possibilities that may explain this finding. 
The issue of age has previously been raised as a key variable in respect to 
urinary porphyrin measurement (Woods et al., 2009, 2010). Porphyrin levels are 
typically higher and more unstable at younger ages, decreasing throughout childhood 
and becoming more stable as the individual approaches adulthood. Therefore, studies 
using older children or adults as controls could be misleading due to natural age-
related variation in urinary porphyrin concentrations. However, the issue of an age-
appropriate control group was addressed in the Shandley et al. (2014) porphyrin 
study by recruiting two age-matched control groups. Furthermore, any unanticipated 
age variation was addressed by controlling for age in the analysis. Interestingly 
though, in contrast to our study, the results of an earlier, smaller study by Kern et al. 
(2011) found a significant difference between children with ASD and an age- and 
sex-matched control group. 
A second issue in regards to age also needs to be considered. The Shandley et 
al. (2014) porphyrin study recruited children within the typical ASD diagnostic age-
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range (2-6 years). This age-range is both considerably younger and more restricted 
than those used in other porphyrin studies. The majority of prior porphyrin studies 
have recruited children from 2-12 years of age, effectively doubling the upper limit 
of the Shandley et al. (2014) study. As mentioned above, porphyrins tend to be 
higher, and less stable among younger age groups. Consequently, it is possible that 
urinary porphyrins are an ill-suited measure of Hg damage among younger cohorts. 
Further studies examining the validity of urinary porphyrins as a marker of Hg 
damage among infants and pre-school aged children would be a valuable addition to 
the knowledge base on porphyrins.
The Shandley et al. (2014) study is the first in the series of studies exploring 
ASD and urinary porphyrins to align with the DSM 5 nosology, merging children 
with a diagnosis of Autistic Disorder, Asperger’s Disorder and PDD-NOS into the 
single dimension of ASD. ASD is undeniably a broad spectrum given that it includes 
severely disabled children at one end of the spectrum who may require intensive,
specialised lifelong care, while the other end of the spectrum includes children who 
are often able to attend mainstream schooling and will possibly be able to go on to 
live an independent adult life. There is some suggestion that elevated porphyrin 
levels may be more pronounced among more severely disabled groups of children.
Consider, for example, the study by Nataf et al. (2006), where the urinary 
porphyrin markers associated with Hg (5CP, PrCP, and CP) were significantly 
elevated among children with AUT in comparison to a control group, however, they 
were not significantly elevated in children with Asperger’s Disorder or PDD-NOS. If 
the children diagnosed with Autistic Disorder, Asperger’s and PDD-NOS were 
grouped according to the DSM 5, one wonders if there would be a significant 
difference between the newly formed ASD group and the control group. Clearly the 
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classification issue driven by DSM-5 whereby previously distinct diagnostic groups 
are collapsed into a single ASD entity needs to be accounted for by any future 
research in this area.
Pink Disease
Pink disease survivors are a diminishing population of individuals with an 
idiosyncratic sensitivity to Hg and therefore represent a unique opportunity to better 
understand the clinical ramifications and mechanisms of Hg on human health. Few 
cases of pink disease have been diagnosed since the 1960s following the removal of 
calomel from medicinal products used with newborns and infants, primarily teething 
powders. Consequently, pink disease survivors are an ageing cohort of the population 
with the youngest afflicted individuals typically aged in their 50-60s. 
Shandley and Austin (2011) found ASD to be significantly higher (6-7 fold) 
among the grandchildren of pink disease survivors in comparison to the general 
population matched by birth year. Furthermore, the results indicate that there was not 
an elevated risk for disease generally among the offspring of pink disease survivors,
but rather a specific risk for ASD. The results are therefore consistent with the 
hypothesis that a hypersensitivity to Hg may be a heritable risk factor for the 
development of ASD. However, the results of this study do not provide information 
as to the mechanism by which a sensitivity to Hg might be inherited. Some possible 
mechanisms by which this may occur have been identified by others. For example, 
elevated oxidative stress and decreased glutathione have been identified as a possible 
mechanism by which Hg may induce ASD (James et al. 2004; Geier & Geier, 2006a;
Youn et al. 2010). An individual low in glutathione would have both a diminished 
capacity to minimise oxidative damage produced by Hg and excrete the toxicant. A 
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recent case-control study by Stamova et al. (2011) investigated gene expression and 
blood Hg levels in boys diagnosed with ASD and an age-matched control group of 
typically developing boys. The authors identified the expression of 189 genes to 
correlate with Hg levels in the ASD group alone. The primary biological function of 
the genes was reported to be cell morphology, amino acid metabolism, and antigen 
presentation. This suggests that the underlying mechanism may relate to the inability 
of children with ASD to effectively metabolise toxic substances. 
An issue for consideration in the Shandley and Austin (2011) study is the use 
of the second generation of descendants (grandchildren) of pink disease survivors. 
Obtaining comparable ASD prevalence rates was a critical component of the study, 
however, in Australia, only one ASD prevalence study has been conducted 
(MacDermott et al., 2008). This had a substantial impact on the study as the mean 
age of the children of pink disease survivors was 37 years and Australian general 
population ASD prevalence rates are not available for this cohort born in the 1960s 
and 1970s. Consequently the next best option was to compare the prevalence rates of 
grandchildren who could be matched for birth year. Whether this issue mediates or 
obscures the results in some manner is unclear.
A further issue for consideration is the lack of additional information collected 
in respect to other variables hypothesised to play a role in the development of ASD, 
such as parental age, maternal or neonatal infection, and birth weight. Pink disease 
survivors report a wide range of medical issues experienced during adulthood. It is 
possible that ASD may only be indirectly associated with pink disease and therefore 
Hg. That is, pink disease survivors may be more likely to experience biomedical 
issues due to Hg which are responsible for the higher prevalence of ASD among the 
descendants as opposed to the descendants inheriting a sensitivity to Hg. For 
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example, fertility issues have been reported among pink disease survivors, such as 
Young’s syndrome which is a condition relating to male infertility (Hendry et al.,
1993). Fertility issues may lead to a greater frequency of babies in the low birth 
weight range, a variable that has been associated with ASD. There is a clear need for 
more research in this area, and given pink disease survivors are a rare ageing cohort 
of the population, the need is urgent. 
Strengths
The body of work presented in this thesis has made a significant and unique 
contribution to the body of research exploring the potential association between Hg 
and ASD. Firstly, the two empirical studies utilising urinary porphyrins as a measure 
of Hg damage (Austin & Shandley, 2008; Shandley et al., 2014) remain the only 
published studies of their type conducted in Australia. The Shandley et al. (2014) 
paper offers a particularly unique perspective to the collection of porphyrin studies as 
this was a well powered study with well-defined groups and, in contrast to all other 
comparable published studies, found no significant differences between an ASD 
group and two healthy control groups. Consequently, the results from the paper do 
not support the assumption that there is a relationship between Hg and ASD. Despite 
this, there remains a question over the reliability of urinary porphyrins as a measure 
of Hg toxicity among very young (infants/pre-school aged) children, and this 
requires further investigation.
The Shandley and Austin (2011) paper was the first to examine the notion of 
individual susceptibility to Hg among a cohort of pink disease survivors. A 
substantial recruitment campaign was carried out in conjunction with the Australian 
Pink Disease Support Group (the only group in the world dedicated to pink disease 
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survivors) allowing current and past members from their membership list to be 
contacted. Given pink disease survivors are largely an elderly cohort, a variety of 
response format options were provided allowing pink disease survivors to select the 
option with which they were most comfortable. Working closely with the Pink 
Disease Support Group and providing a variety of response format options created 
the best chance for recruiting as many remaining pink disease survivors into the 
study as possible. In order to minimise response bias, the purpose of the study was 
withheld from participants with recruitment materials merely stating that the 
researchers were interested in the health outcomes of their descendants. The study 
was furthered strengthened by matching comparison groups for age and birth year. 
The study found that descendants of pink disease survivors were significantly more 
likely to have a diagnosis of ASD; critically highlighting that heritability of Hg 
sensitivity may be a key factor in understanding the aetiology of ASD.
Limitations
The published studies presented in this thesis need to be viewed in light of a 
number of limitations. Firstly, a limitation common to all three empirical studies 
(Austin & Shandley, 2008; Shandley & Austin, 2011; Shandley et al., 2014) was the 
lack of independent clinical assessments. Due to cost of conducting assessments, the 
sample sizes and location of participants (across rural and metropolitan regions in 
most states and territories in Australia) it was not economically feasible to conduct
independent clinical assessments to validate the accuracy of all self-reported 
diagnoses. It is reasonable, therefore, to assume that a small number of diagnostic 
errors may be present; however, where possible, any doubts that arose over diagnosis 
were followed up with the individual participant/family. Furthermore, a cautious 
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approach was adopted whereby strict inclusion criteria was applied to each study, 
only accepting a child as an ASD case if an assessment had been carried out by a
qualified health professional. Children who were in the process of undergoing an 
ASD assessment or who exhibited symptoms seemingly consistent with an ASD 
diagnosis were not accepted as an ASD case. Consequently, if any errors in diagnosis
did occur, it is unlikely that they did so in large enough numbers to influence the 
results of any of the studies.  
As previously discussed, the presence of elevated levels of 5CP, PrCP and CP 
are associated with heavy metal toxicity, with PrCP specifically associated with Hg 
toxicity. However, PrCP is an unstandardised porphyrin (largely unvalidated 
biochemical entity). For this reason, not all laboratories that conduct porphyrin 
testing include PrCP in their urinary porphyrin profiles. Until such time as PrCP is 
standardised (if this is to occur), studies placing emphasis on the importance of this 
porphyrin in respect to Hg toxicity need to be viewed cautiously.  
A further limitation not raised in the Shandley et al. (2014) paper is that the 
analyses did not consider exposure to contaminants. As discussed in Chapter 3, Hg is 
ubiquitous in the environment and humans are particularly exposed through dental 
amalgam, diet, vaccinations, and geographic location. It is possible that the study 
groups may have been differentially exposed to Hg, and whether this would have had 
an impact on the results is unknown. However, it is recommended that future studies 
take into account as many contaminant variables as possible.   
Future research
The number of studies investigating urinary porphyrins and ASD are steadily 
increasing. The studies presented in this thesis suggest that there is need to consider 
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the reliability of urinary porphyrins as a measure of Hg damage, particularly in 
regards to younger cohorts. Longitudinal studies investigating changes in porphyrin 
levels across age between children with ASD and normally developing children 
would substantially improve the knowledge base on urinary porphyrins and what 
value they have in furthering our understanding of any possible association between 
Hg and ASD. There is also need for a replication study of the Shandley et al. (2014) 
study. The results of this study were markedly different from previous porphyrin 
studies and it is important to determine whether the results can be replicated.
Based upon the results presented in this thesis, further genetic and biological 
studies, particularly with pink disease survivors, may further our understanding of 
the mechanisms by which Hg may induce ASD. For example, studies seeking to 
identify genetic variables that may differentiate pink disease survivors from non-pink 
disease survivors are encouraged. Genetic markers unique to pink disease survivors 
may play a critical role in one’s susceptibility to Hg. It would then be beneficial to 
explore any identified genetic markers among individuals with ASD. Moreover, 
enquiry into potential mechanisms by which Hg could disrupt epigenetic regulation 
is important, in addition to determining whether there is a transgenerational effect
(i.e., whether epigenetic changes are passed from parent to offspring).
Further research examining the association between pink disease and other 
hypothesised risk factors in the pathogenesis of ASD (i.e., birth weight, parental age, 
maternal/neonatal infection and birth weight) would also be highly beneficial. To 
further establish whether an individual sensitivity to Hg is heritable it is necessary to 
determine whether other ASD risk factors are common among pink disease 
survivors. If this is the case, then the apparent relationship between Hg and ASD 
demonstrated in the Shandley and Austin (2011) paper may in fact be an indirect 
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relationship, mediated by biomedical issues experienced by pink disease survivors as 
a consequence of Hg.
Conclusion
Research investigating possible environmental triggers in the pathogenesis of 
ASD has increased dramatically in recent years. In particular, Hg as a possible 
environmental trigger has been the topic of much debate since the publication of a 
paper by Bernard et al. (2001) which proposed that ASD is a form of Hg poisoning. 
Although some of the evidence to date is compelling, scientifically, it is not 
definitive. The present thesis took an interdisciplinary approach to investigate the 
potential association between Hg and ASD. Three empirical studies were conducted, 
two biological studies utilising urinary porphyrins as the main outcome measure, and 
a heritability study examining whether an individual sensitivity to Hg may be 
genetic. 
The two published studies (Austin & Shandley, 2008; Shandley et al., 2014) 
undertaken to investigate Hg toxicity among Australian children via the use of 
urinary porphyrin profiles ultimately failed to support the association between Hg 
and ASD. The first study conducted in the present thesis (Austin & Shandley, 2008), 
a pilot trial, found a significant difference between the porphyrin levels of a small 
convenience sample of Australian children with ASD in comparison to the control 
groups of three other studies (Geier & Geier, 2007; Minder & Schneider-Yin, 1996; 
Nataf et al., 2006), indicating that a further study was warranted. However, the larger 
case-control study (Shandley et al., 2014), designed to address the limitations of the 
pilot trial (small sample size, lack of appropriate control group) and extend upon 
previous porphyrin studies, failed to find a significant difference in urinary 
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porphyrins levels between three groups: (1) children diagnosed with ASD; (2) 
children with a sibling diagnosed with ASD (sibling control group); and (3) children 
with no known blood relatives diagnosed with an ASD (external control group). 
Furthermore, neither group membership, nor ASD severity could be predicted based 
upon urinary porphyrins. However, this result must be considered in light of the 
potential unreliability of urinary porphyrins as a measure of Hg damage for young 
children. 
The Shandley & Austin (2011) study provides support for a possible heritable 
and/or genetic basis for a sensitivity to Hg and warrants further investigation into 
mechanisms by which this may occur. In addition, it is necessary to determine the 
nature of the relationship between pink disease and other hypothesised risk factors 
for ASD in order to establish whether there is a direct or indirect link between pink 
disease, ASD and Hg.
Based upon the studies undertaken in the present thesis it is not possible to 
definitively conclude whether there is an association between Hg and ASD. The 
apparent association between Hg and ASD is clearly complex and likely mediated by 
several factors. Mediating factors may vary across individuals based on physiological 
characteristics (i.e., genetics, age, weight and gender) and/or Hg characteristics (i.e., 
age of exposure, form, and dose). Several challenging, multifactorial studies will be 
required to understand the nature of the association between Hg and ASD, if one 
indeed exists.
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